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I. INTRODUCTION 
In May of 2000, the Massachusetts Department of Public Health, Center for 
Environmental Health (MDPH, CEH) released a Public Health Assessment for public 
comment for the Glen Street neighborhood area (a.k.a. Milham Brook area) in 
Marlborough, MA (MDPH 2000) (see Figures 1 and 2).  The Public Health Assessment 
evaluated available environmental sampling data (i.e., surface soil and surface water) and 
the potential for health effects associated with historical pesticide use at a former apple 
orchard in this area of Marlborough.  The Public Health Assessment was initiated when 
the CEH and the U.S. Agency for Toxic Substances and Disease Registry (ATSDR) 
received a petition request expressing concern about illness, particularly cancer, in long-
term residents living near the former orchard (Bucchino et al. 2000).  Residents cited a 
number of concerns including a suspected increase in the incidence of cancers in the 
surrounding neighborhood and the known use of pesticides in the former orchard.  
In 1999, the Board of Health for the City of Marlborough had contacted the CEH 
about a resident’s concerns over the number of individuals with cancer, including 
leukemia, in the Conrad Road neighborhood of Marlborough.  Conrad Road is in the 
same neighborhood as Glen Street.  Also, in 1999, the Massachusetts Cancer Registry 
(MCR) released the report Cancer Incidence in Massachusetts 1990-1995: City and 
Town Supplement (MCR 1999).  A preliminary review of these surveillance data for 
Marlborough indicated that the majority of cancer types occurred at or below expected 
rates during 1990-1995.  However, it was noted that some cancer types were elevated and 
that the increases represented statistically significant increases in the number of 
diagnoses above the expected number of cases.  Therefore the Public Health Assessment 
recommended additional investigation of the patterns or trends in the incidence of 
leukemia and lung and liver cancers at a smaller geographic level within Marlborough. 
In response to these observations and to further address environmental health 
concerns of the community, the CEH’s Community Assessment Program (CAP) 
evaluated the incidence of leukemia and cancers of liver and the lung in the city of 
Marlborough and for smaller geographic areas within the city for the 21-year time period 
1982-2002.  In addition, this evaluation includes a brief summary of the results of the 
Public Health Assessment for public comment regarding environmental contamination at 
the former apple orchard, as well as information regarding other sites of environmental 
concern in Marlborough, to determine the likelihood that potential environmental 
exposures could play a role in the pattern of cancer in the city.  MDPH recently finalized 
the Public Health Assessment (MDPH 2006). 
II. BACKGROUND AND STATEMENT OF ISSUES 
As described in the Public Health Assessment (MDPH 2000), the former apple 
orchard in Marlborough comprises 82 acres and is bordered to the north by Route 20, to 
the east and south by Glen Street, and to the west by Ames Street (see Figure 2).  Milham 
Brook, a tributary of Milham Reservoir and one of the drinking water sources for 
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Marlborough, runs through the site.  The site was used as an apple orchard until the 
1950s, during which time various pesticides, including lead arsenate, were applied.  The 
primary contaminants of concern at the site included arsenic, 1,1,1-trichloro-2,2-bis[p-
chlorophenyl]ethane (DDT) and related compounds [i.e., 1,1-dichloro-2,2-bis[p-
chlorophenyl]ethylene (DDE) and 1,1-dichloro-2,2-bis[p-chlorophenyl]ethane (DDD)], 
and dieldrin. 
Cancers or tumors of concern that have been associated or possibly associated 
with exposure to compounds detected at the former apple orchard property in 
Marlborough in either animal or human studies include cancers of the kidney (arsenic), 
liver (arsenic, DDT, and dieldrin), lung (arsenic), bladder (arsenic), thyroid (dieldrin), 
skin (arsenic), as well as Hodgkin’s disease (DDT) and non-Hodgkin’s lymphoma 
(DDT).  Based on this information, the potential for environmental exposures at the 
former apple orchard, and a review of preliminary data on the incidence of cancer in 
Marlborough, the Public Health Assessment recommended further evaluation of three 
cancer types (i.e., leukemia, liver cancer, and lung cancer) in Marlborough, with 
particular attention to the Glen Street neighborhood (MDPH 2000). 
III. OBJECTIVES 
This report provides a descriptive evaluation of the occurrence of certain cancer 
types in the city of Marlborough.  It provides a comparison of the incidence of selected 
cancer types in this community with the incidence of cancer in the state of Massachusetts 
as a whole.  The state of Massachusetts is used as a comparison to provide a stable, 
standard population to calculate and compare cancer incidence rates.  Additionally, 
available information about risk factors related to the development of cancer, including 
environmental factors, was evaluated. 
Because the evaluation described in this report is a descriptive analysis of cancer 
incidence data, it cannot be used to establish a causal link between a particular risk factor 
and the development of cancer.  In addition, this analysis cannot determine the cause of 
any one individual’s cancer diagnosis.  However, the results can be useful in identifying 
common patterns or trends in cancer incidence in a geographic context.  This type of 
analysis can be helpful in determining if a common etiology (or cause) for certain cancer 
types is possible and can serve to identify areas where further public health investigations 
or actions may be warranted.  Descriptive analyses may also indicate that an excess of 
known risk factors associated with a particular cancer type exists in a certain geographic 
area.  Despite their limitations, descriptive studies can help identify patterns that may 
indicate an environmental exposure is related to a pattern of cancer.  The purpose of this 
investigation was to determine whether unusual patterns of cancer incidence existed at a 
smaller geographic level within Marlborough and specifically the Glen Street 
neighborhood of the city, and to evaluate whether future public health actions are 
warranted. 
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IV. METHODS FOR ANALYZING CANCER INCIDENCE DATA 
A. Case Identification/Definition 
Cancer incidence data (i.e., new diagnoses of cancer cases) for leukemia, liver 
cancer, and lung cancer were obtained for the city of Marlborough from the 
Massachusetts Cancer Registry (MCR), a division of the MDPH Center for Health 
Information, Statistics, Research and Evaluation.  The MCR is a population based 
surveillance system that began collecting information on Massachusetts residents 
diagnosed with cancer in the state in 1982.  All newly diagnosed cancer cases among 
Massachusetts residents are required by law to be reported to the MCR within six months 
of the diagnosis (M.G.L. C.111s.111B). 
 
At the initiation of this investigation, the 21-year time period 1982-2002 
constituted the period for which the most recent and complete cancer incidence data were 
available from the MCR.  The observed number of cancer cases reported in this 
evaluation was defined as cases reported to the MCR as a primary cancer diagnosed 
among residents of Marlborough.  Individuals were selected for inclusion based on the 
address reported to the hospital or reporting medical facility at the time of diagnosis. 
 
The term “cancer” is used to describe a variety of diseases associated with 
abnormal cell and tissue growth.  Epidemiology studies have revealed that different types 
of cancer are individual diseases with separate causes, risk factors, characteristics and 
patterns of survival (Bang 1996).  Cancers are classified by the location in the body 
where the disease originated (the primary site) and the tissue or cell type of the cancer 
(histology).  Therefore, each of the cancer types reviewed in this report was evaluated 
separately.  Cancers that occur as the result of the metastasis or the spread of a primary 
site cancer to another location in the body are not considered as separate cancers and 
therefore were not included in this analysis. 
 
Occasionally, the MCR research file may contain duplicate reports of cases.  The 
data discussed in this report have been controlled for duplicate cases by excluding them 
from the analyses.  Duplicate cases are additional reports of the same primary site cancer 
case.  The decision that a case was a duplicate and should be excluded from the analyses 
was made by the MCR after consulting with the reporting hospital/diagnostic facility and 
obtaining additional information regarding the histology and/or pathology of the case.  
However, reports of individuals with multiple primary site cancers were included.  A 
multiple primary cancer case is defined by the MCR as a new cancer in a different 
primary site, or a new cancer of the same histology (cell type) as an earlier cancer, if 
diagnosed in the same primary site (original location in the body) more than two months 
after the initial diagnosis (MCR 2003).  Therefore, duplicate reports of an individual 
diagnosed with cancer were removed from the analyses whereas individuals who were 
diagnosed with more than one primary site cancer were included as separate cases.  In the 
city of Marlborough during 1982-2002, 13 duplicate reports were identified and excluded 
from the analysis. 
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B. Calculation of Standardized Incidence Ratios (SIRs) 
To determine whether elevated numbers of cancer cases have occurred in 
Marlborough or its census tracts (CTs), cancer incidence data were tabulated by age 
group and gender to compare the observed number of cancer cases in each census tract to 
the number that would be expected based on the statewide cancer experience.  
Standardized incidence ratios (SIRs) were calculated for the 21-year time period 1982-
2002, for four smaller time periods (i.e., 1982-1986, 1987-1992, 1993-1998, and 1999-
2002), for each of the three cancer types for the six census tracts in Marlborough and the 
city as a whole. 
 
In order to calculate incidence rates, it is necessary to obtain accurate population 
information.  The population figures used in this analysis were interpolated based on 
1980, 1990 and 2000 U.S. Census data for each CT in Marlborough for the 1982-2002, 
1982-1986, 1987-1992, and 1999-2002 time periods (U.S. Census Bureau 1980, 1990 and 
2000).  Midpoint population estimates were calculated for each time period evaluated.  
To estimate the population between census years, an assumption was made that the 
change in population occurred at a constant rate throughout the ten-year interval between 
each census.  For example U.S. Census data for the years 1990 and 2000 were used to 
find the midpoint population for the 1993-1998 analysis.    U.S. Census data for the year 
2000 were used in the 1999-2002 analysis (U.S. Census Bureau 2000). 
 
Because accurate age group and gender specific population data are required to 
calculate SIRs, the CT is the smallest geographic area for which cancer rates can be 
accurately calculated.  Specifically, a CT is a smaller statistical subdivision of a county as 
defined by the U.S. Census Bureau.  Census tracts usually contain between 2,500 and 
8,000 persons and are designed to be homogenous with respect to population 
characteristics (U.S. Census Bureau 1990). 
 
The location and boundaries of the Marlborough census tracts are illustrated in 
Figure 1.  The U.S. Census Bureau has designated six census tracts (CTs 3211-3216) to 
subdivide the city of Marlborough.  Census tracts 3211 and 3214 are the least populated 
census tracts and are located on the western and eastern sides of the city, respectively.   
The remaining four census tracts (i.e., 3212, 3213, 3215, and 3216) subdivide the 
remainder of the city.  Each of these four census tracts contains a portion of the more 
populated city center.  The Glen Street neighborhood and former orchard property are 
located in CT 3214 (see Figure 2). 
C. Interpretation of Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what 
might be expected if the population had the same cancer experience as some larger 
comparison population designated as “normal” or average.  Usually, the state as a whole 
is selected to be the comparison population.  Using the state of Massachusetts as a 
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comparison population provides a stable population base for the calculation of incidence 
rates. 
Specifically, an SIR is the ratio of the observed number of cancer cases to the 
expected number of cases multiplied by 100.  The population structure of each town is 
adjusted to the statewide incidence rate to calculate the number of expected cancer cases.  
The SIR reflects a comparison of the number of cases in the town compared to the 
statewide rate, using the specific age/sex structure of the statewide rate as the weights to 
determine the expected number of cases in each town.  Therefore, because each 
community has different population characteristics, town-to-town or census tract 
comparisons are not possible. 
An SIR of 100 indicates that the number of cancer cases observed in the 
population being evaluated is equal to the number of cancer cases expected in the 
comparison or “normal” population.  An SIR greater than 100 indicates that more cancer 
cases occurred than expected an SIR less than 100 indicates that fewer cancer cases 
occurred than expected.  Accordingly, an SIR of 150 is interpreted as 50% more cancer 
cases than the expected number; an SIR of 90 indicates 10% fewer cancer cases than 
expected. 
Caution should be exercised, however, when interpreting an SIR.  The 
interpretation of an SIR depends on both the size and the stability of the SIR.  Two SIRs 
can have the same size but not the same stability.  For example, an SIR of 150 based on 
four expected cases and six observed cases indicates a 50% excess in cancer, but the 
excess is actually only two cases.  Conversely, an SIR of 150 based on 400 expected 
cases and 600 observed cases represents the same 50% excess in cancer, but because the 
SIR is based upon a greater number of cases, the estimate is more stable.  It is very 
unlikely that 200 excess cases of cancer would occur by chance alone.  As a result of the 
instability of incidence rates based on small numbers of cases, SIRs were not calculated 
when fewer than five cases were observed for a particular cancer type. 
D. Calculation of the 95% Confidence Interval 
To interpret or measure the stability of an SIR, the statistical significance of each 
SIR was assessed.  The statistical significance of an SIR was assessed by calculating a 
95% confidence interval (95% CI) for each SIR to determine if the observed number of 
cases is “significantly different” from the expected number or if the difference may be 
due solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of 
estimated SIR values that have a 95% probability of including the true SIR for the 
population.  If the 95% CI range does not include the value of 100, then the study 
population is significantly different from the comparison or “normal population.”  
“Significantly different” means there is less than a 5% chance that the observed 
difference (either increase or decrease) is the result of random fluctuation in the number 
of observed cancer cases. 
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For example, if a confidence interval does not include 100 and the interval is 
above 100 (e.g., 105-130), then this means statistically there is a significant excess in the 
number of cancer cases.  Similarly, if the confidence interval does not include 100 and 
the interval is below 100 (e.g., 45-96), then statistically this means that the number of 
cancer cases is significantly lower than expected.  If the confidence interval range 
includes 100, then the true SIR may be 100, and it cannot be concluded with sufficient 
confidence that the observed number of cases is not the result of chance.  In this case, it 
cannot be determined with certainty that the difference between the observed number of 
cases reflects a real cancer increase or decrease.  It is important to note that statistical 
significance does not necessarily imply public health significance.  Determination of 
statistical significance is just one tool used to interpret SIRs. 
 
In addition to the range of the SIR estimates contained in the confidence interval, 
the width of the confidence interval also reflects the stability of the SIR estimate.  For 
example, a narrow confidence interval (e.g., 103-115) allows a fair level of certainty that 
the calculated SIR is close to the true SIR for the population.  A wide interval (e.g., 85-
450) leaves considerable doubt about the true SIR, which could be much lower than or 
much higher than the calculated SIR.  This would indicate an unstable statistic.  Again, 
due to the instability of incidence rates based on small numbers of cases, statistical 
significance was not assessed when fewer than five cases were observed. 
E. Evaluation of Risk Factor Information 
Available information reported to the MCR related to risk factors for cancer 
development was reviewed and compared to known or established incidence patterns for 
the cancer types evaluated in this report.  This information is collected for each individual 
at the time of cancer diagnosis and includes age at diagnosis, histology (cell type), 
smoking status, and occupation.  One or even several factors acting over time can be 
related to the development of cancer.  For example, tobacco use has been linked to lung 
and bladder cancers.  Other risk factors may include lack of crude fiber in the diet, high 
fat consumption, alcohol abuse, and reproductive history.  Heredity, or family history, is 
an important factor for several cancers.  To a lesser extent, some occupational exposures, 
such as jobs involving contact with asbestos, have been shown to be carcinogenic (cancer 
causing).  Environmental contaminants have also been associated with certain types of 
cancer.  The available risk factor information from the MCR was evaluated for the cancer 
types assessed for the city of Marlborough.  However, information about personal risk 
factors (e.g., family history, hormonal events, diet, etc.) that may also influence the 
development of cancer is not collected by the MCR or any other available source and 
therefore was not evaluated in this investigation. 
F. Geographic Distribution 
The geographic distribution of individuals diagnosed with leukemia, liver cancer, 
or lung cancer in Marlborough was determined using available address information from 
the MCR indicating residence at diagnosis.  This information was mapped for each 
individual using a computerized geographic information system (GIS) (ESRI 2005).  This 
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allowed for the assignment of CT location for each case as well as an evaluation of the 
spatial distribution of cases at a smaller geographic level within census tracts (i.e., 
neighborhoods).  The geographic distribution was assessed using a qualitative evaluation 
of the point pattern of cases within the city and within each census tract.  In instances 
where the address information was incomplete (i.e., did not include specific streets or 
street numbers), efforts were made to research those cases using telephone books and city 
residential lists issued within two years of an individual’s diagnosis.  Address locations 
were also confirmed by site visits to the area.  For confidentiality reasons, maps of the 
locations of individuals diagnosed with cancer cannot be provided in this report. 
G. Cancer Incidence in the Glen Street Neighborhood 
As described previously, this evaluation was prompted by concerns about a 
suspected increase in the incidence of cancers among residents of the Glen Street 
neighborhood, thought to be related to environmental contamination associated with the 
former apple orchard in Marlborough.  To determine whether an atypical pattern of any 
type of cancer (in addition to leukemia, liver cancer, and lung cancer) exists in the Glen 
Street area of Marlborough, CAP staff reviewed MCR data files to confirm cancer 
diagnoses reported among residents of Glen Street and the adjacent streets including 
Mount Royal Avenue, Foley Road, McGee Avenue, Burns Road, Conrad Road, Ripley 
Avenue, Hurley Circle, Tucker Avenue, Flynn Avenue, Teller Street, MacKay Drive, and 
Sandini Street.  As noted above, the 21-year period from 1982-2002 constitutes the time 
period for which the most complete and recent cancer incidence data are available from 
the MCR.  However, we also reviewed MCR data files for cancer diagnoses in this area 
reported from 2003 to the present.1 
V. RESULTS OF CANCER INCIDENCE ANALYSES 
The following sections present cancer incidence rates for leukemia, liver cancer, 
and lung cancer for Marlborough and its individual census tracts for the 21-year time 
period 1982-2002, as well as for four smaller time periods (i.e., 1982-1986, 1987-1992, 
1993-1998, and 1999-2002).  Analysis by census tracts or smaller geographic area helps 
in understanding whether the elevated incidence of a certain cancer type observed city-
wide may be explained by an increase in cases in a particular geographic area of the city.  
Tables 1 through 15 summarize cancer incidence data for Marlborough and its census 
tracts for the time periods evaluated in this report.  Figures 3 through 5 also provide a 
summary of cancer incidence data by census tract in Marlborough.  The locations and 
boundaries of census tracts in Marlborough are presented in Figure 1. 
                                                          
1 Standardized incidence ratios beyond the year 2002 cannot be calculated due to incomplete cancer 
incidence data for the state in more recent years.  Although all newly diagnosed cases of cancer are 
required to be reported to the MCR with six months of diagnosis (M.G.L. C.111 s. 111B), due to intensive 
efforts to ensure data quality, there is a significant lag time between diagnosis and reporting.  Therefore 
data for more recent years (i.e., 2003 to present) cannot be considered complete. MCR data reported here 
are current through May 12, 2006. 
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A. Leukemia 
1. Leukemia Incidence in Marlborough, MA 
Overall, the incidence of leukemia in Marlborough, MA was statistically 
significantly elevated among males and females combined during the 21-year time period 
1982-2002 (87 cases observed vs. 59.6 expected, SIR=146, 95% CI=117-180).  When 
evaluated separately by gender, females experienced a statistically significant elevation in 
rates of leukemia compared to the statewide experience.  The rate of leukemia in males 
approached statistical significance.  Among females, 42 diagnoses were observed where 
27.1 were expected (SIR=155, 95% CI=112-209).  Also, 45 diagnoses of leukemia were 
reported among males in Marlborough where approximately 33 were expected (SIR=136, 
95% CI=99-182).  A summary of these data are provided in Table 1.  Also, an additional 
seven diagnoses of leukemia were reported in Marlborough from 2003 to the present.  
This represents an average of two new cases of leukemia each year since 2003 compared 
to the average of four new cases per year during the 1982-2002 time period. 
 
To determine whether temporal trends (or trends over time) in leukemia incidence 
may have occurred, incidence data were evaluated for four smaller time periods (i.e., 
1982-1986, 1987-1992, 1993-1998, and 1999-2002).  Review of these data revealed that 
residents of Marlborough, MA experienced elevated rates of leukemia during the first 
three time periods, but leukemia was not elevated in the most recent time period 
evaluated.  These elevations were statistically significant for males and females combined 
during 1987-1992 and 1993-1998 as well as for males during 1987-1992 and females 
during 1993-1998.  During 1982-1986, 16 individuals in Marlborough were diagnosed 
with leukemia compared to approximately 12 expected.  During 1987-1992, a total of 26 
diagnoses were reported where 14.4 were expected (SIR=180, 95% CI=118-264).  
During 1993-1998, 30 individuals in Marlborough were diagnosed with leukemia while 
approximately 18 cases were expected (SIR=165, 95% CI=111-236).  Finally, 15 
diagnoses of leukemia in Marlborough were reported to the MCR during 1999-2002 
compared to about 16 expected (SIR = 94) (see Tables 2-5). 
2. Leukemia Incidence in Marlborough Census Tracts 
To determine whether the trends observed in the incidence of leukemia in 
Marlborough reflect increased rates in particular geographic areas of the city, incidence 
data were reviewed for each census tract in Marlborough.  During the 21-year time period 
1982-2002, leukemia occurred more often than expected in five of Marlborough’s six 
census tracts.  Therefore, based on these data, the increased rate of leukemia observed 
citywide does not appear to be attributable to an elevation in any one census tract alone.  
Residents in one census tract experienced statistically significant elevations in the 
incidence of leukemia.  Specifically, in CT 3215, 23 individuals were diagnosed with 
leukemia where approximately 12 diagnoses were expected (SIR=197, 95% CI=125-
295).  This increase was the result of a statistically significant elevation in the incidence 
of leukemia among females in this census tract.  In CT 3214, where the former orchard 
and Glen Street neighborhood are located, leukemia occurred at approximately the 
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expected rate; five individuals were diagnosed with leukemia in this census tract where 
approximately six diagnoses were expected.  A summary of leukemia incidence by 
census tract for the time period 1982-2002 is provided in Table 1. 
 
Although SIRs were not calculated for many of the census tracts in smaller time 
periods due to the small number of observed cases (i.e., less than five), the expected 
number of cases was calculated to determine whether excess numbers of leukemia 
diagnoses were occurring in any area of Marlborough over time.  In general, with some 
exceptions, leukemia occurred approximately at or below the expected rates in most 
Marlborough CTs during the earliest time period evaluated, 1982-1986 (see Table 2).  A 
statistically significant elevation was observed in CT 3215 due primarily to an elevation 
among males in this census tract during this time period.  During 1987-1992, the 
observed number of leukemia diagnoses was within one or two cases of the expected 
number for most census tracts (see Table 3).  In CT 3213, a statistically significant 
elevation of leukemia occurred.  Again, the elevation was due to a statistically significant 
elevation among males where 6 cases were observed vs. 1.6 expected (SIR=366, 95% 
CI=134-796).  Residents experienced higher than expected rates of leukemia in the 
majority of Marlborough CTs during 1993-1998 (see Table 4).  In CT 3215, a statistically 
significant elevation was noted among females where 5 cases were observed vs. 1.6 cases 
expected.  Males in CT 3215 experienced leukemia at a less-than-expected rate during 
1993-1998.  Again in the most recent time period of 1999-2002 the observed number of 
leukemia diagnoses was within one or two cases of the expected number for most census 
tracts (see Table 5).  For most of the elevations observed, the wide confidence intervals 
associated with these elevations suggest that the calculated SIRs are somewhat unstable.  
In CT 3214, where the Glen Street neighborhood is located, leukemia occurred at about 
the rate expected during each of the time periods evaluated. 
B. Liver Cancer  
1. Liver Cancer Incidence in Marlborough, MA 
During the 21-year time period 1982-2002, a statistically significant elevation in 
the incidence of liver cancer was observed among residents of Marlborough (28 observed 
vs. 18.0 expected, SIR=156, 95% CI=103-225).  Liver cancer occurred more often than 
expected among both males and females when evaluated separately by gender (18 
observed diagnoses among males vs. 13.0 expected; 10 observed diagnoses among 
females vs. 4.9 expected) (see Table 6).  Also, an additional five diagnoses of liver cancer 
were reported in Marlborough from 2003 to the present.  This represents an average of 
one new case of liver cancer each year since 2003 compared to the average of one new 
case per year during the 1982-2002 time period. 
 
The overall rate of liver cancer in Marlborough observed during 1982-2002 was 
due to elevations in the incidence of this cancer type during three of the smaller time 
periods, 1982-1986, 1987-1992, and 1993-1998.  During 1982-1986, five individuals 
were diagnosed with liver cancer versus 2.5 diagnoses expected.  During 1987-1992, six 
diagnoses were reported where 3.7 were expected.  During 1993-1998, ten diagnoses of 
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liver cancer were observed in Marlborough where 5.6 diagnoses were expected.  
However, none of these elevations was statistically significant.  In the most recent time 
period, 1999-2002 seven diagnoses were reported when 6.2 were expected.  Please refer 
to Tables 7-10 for a summary of these data. 
2. Liver Cancer Incidence in Marlborough Census Tracts 
The statistically significant elevation in the incidence of liver cancer observed in 
Marlborough during 1982-2002 was primarily due to elevations in census tracts 3213, 
3215, and 3216 during this time period.  The elevation observed in CT 3213 was 
statistically significant (9 diagnoses observed vs. 3.5 expected, SIR=257).  However, the 
wide 95% confidence interval (117-488) indicates that this is a somewhat unstable 
statistic.  The increase observed in liver cancer in this census tract was due to elevations 
observed among both males and females when evaluated separately.  Approximately 
three additional diagnoses above the expected number of diagnoses occurred in females 
and two additional diagnoses in males.  [Statistical significance could not be determined 
because of the small number of observed diagnoses (i.e., less than five) among males and 
females when evaluated separately.]  In CTs 3215 and 3216, the elevations were based on 
about two or three liver cancer diagnoses over the expected number (CT 3215 – 6 
observed vs. 3.3 expected; CT 3216 – 6 observed vs. 3.2 expected).  Residents of CT 
3214, where the Glen Street neighborhood is located, experienced liver cancer at about 
the expected rate (1 diagnosis observed vs. 1.6 expected) (see Table 6). 
 
SIRs could not be calculated for liver cancer in Marlborough CTs during smaller 
time periods because of the small numbers of observed cases (i.e., less than five).  
However, the observed numbers of cases in each CT was compared to the expected 
number of cases to determine whether liver cancer was occurring at increased rates in 
Marlborough CTs over time.  In general, liver cancer occurred approximately at or below 
expected rates in the majority of CTs during the four time periods evaluated.  However, 
there were a few exceptions.  For example, four individuals (two males and two females) 
were diagnosed with liver cancer in CT 3213 during 1982-1986 where less than one case 
was expected based on the population of this census tract and the statewide rate of liver 
cancer.  In this same census tract, three diagnoses were reported during 1987-1992 where 
approximately one case was expected.  During 1993-1998, liver cancer was diagnosed at 
the expected rate in CT 3213.  In CT 3216, four cases of liver cancer were diagnosed 
during 1993-1998 where one case was expected.  No cases had been diagnosed in CT 
3216 during 1982-1986, and one case (vs. about one expected) was diagnosed during 
1987-1992.  For a summary of liver cancer incidence rates by census tract for the years 
1982-1986, 1987-1992, 1993-1998 and 1999-2002, refer to Tables 7-10.  
C. Lung Cancer 
1. Lung Cancer Incidence in Marlborough, MA 
The incidence of lung cancer was statistically significantly elevated in 
Marlborough during the 21-year time period 1982-2002.  Specifically, 437 individuals 
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were diagnosed with lung cancer where approximately 394.8 diagnoses were expected 
(SIR=111, 95% CI=101-122).  This elevation was primarily due to a statistically 
significant increase in lung cancer among males in this city (263 observed diagnoses vs. 
225.2 expected, SIR=117, 95% CI=103-132).  Lung cancer among females in 
Marlborough was slightly higher than expected during 1982-2002 (174 observed 
diagnoses vs. 169.7 expected, SIR=103) (see Table 11).  Also, an additional 31 diagnoses 
of lung cancer were reported in Marlborough from 2003 to the present.  This represents 
an average of nine new cases of lung cancer each year since 2003 compared to the 
average of 21 new cases per year during the 1982-2002 time period. 
 
Analysis of trends over time suggests that incidence rates for lung cancer 
increased in Marlborough during 1982-1986 and 1987-1992, but declined in 1993-1998 
and 1999-2002.  During 1982-1986, residents of Marlborough experienced an increase in 
the incidence of lung cancer (84 cases observed vs. 77.6 expected), due to an elevation in 
the incidence of this cancer type among males (57 cases observed vs. 49.0 expected) (see 
Table 12).  During 1987-1992, lung cancer was statistically significantly elevated among 
males and females combined (140 cases observed vs. 104.1 expected, SIR=134, 95% 
CI=113-159) and among males when evaluated separately (82 cases observed vs. 61.6 
expected, SIR=133, 95% CI=106-165).  Females in Marlborough also experienced an 
elevated rate of lung cancer during this time period (58 cases observed vs. 42.6 
expected); however, this elevation was not statistically significant (see Table 13).  During 
1993-1998, lung cancer occurred about as expected based on the state rate (119 cases 
observed vs. 120.3 expected, SIR=99).  Similar trends were observed among males and 
females when evaluated separately by gender (see Table 14).  In the most recent time 
period 94 diagnoses were observed when 92.8 were expected (SIR=101).  Males had an 
increased incidence of lung cancer (56 observed vs. 48.1 expected) while females 
experienced a decreased incidence of lung cancer (38 observed vs. 44.7 expected).  
Neither of these results was statistically significant (see Table 15). 
2. Lung Cancer Incidence in Marlborough Census Tracts 
During the 21-year time period 1982-2002, the incidence of lung cancer was 
elevated in three of the six Marlborough census tracts [CT 3212 (83 observed vs. 75.4 
expected), CT 3213 (94 observed vs. 79.1 expected), and CT 3215 (85 observed vs. 75.0 
expected)].  However, none of these elevations were statistically significant.  Residents of 
CT 3214, where the Glen Street neighborhood is located, experienced lung cancer at a 
rate slightly greater than expected based on the state lung cancer experience (41 cases 
observed vs. 36.3 expected).  Based on these data, it appears that the elevation in lung 
cancer incidence observed citywide cannot be attributed to an elevation in any one 
specific census tract alone in Marlborough (see Table 11).   
 
In general, similar trends were observed when males and females were evaluated 
separately by gender.  In CT 3213, males experienced a statistically significant elevation 
in lung cancer during 1982-2002 (65 observed diagnoses vs. 45.0 expected, SIR=144, 
95% CI=111-184) whereas females experienced a lower-than-expected rate of lung 
cancer (29 observed diagnoses vs. 34.1 expected).  Although lung cancer occurred at 
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elevated rates among males and females in the majority of CTs, no elevation other than 
for males in CT 3213 was statistically significant. 
 
In general, no consistent patterns emerged when lung cancer incidence rates in 
Marlborough census tracts were evaluated by smaller time period.  Lung cancer occurred 
more often than expected in CT 3211 during 1982-1986 and 1987-1992 but less often 
than expected during 1993-1998 and 1999-2002.  Residents of census tracts 3212 and 
3213 experienced lung cancer at approximately the rates expected during 1982-1986, at 
statistically significantly elevated rates during 1987-1992, and at lower than expected 
rates during 1993-1998.  During the most recent time period, 1999-2002, CT 3212 
experienced lung cancer incidence lower than expected while CT 3213 experienced a 
higher lung cancer incidence.  Lung cancer occurred approximately at or near the 
expected rate in CT 3214, where the Glen Street neighborhood is located, during the first 
three time periods evaluated while in the latter time period the incidence of lung cancer 
was slightly higher than expected.  In CT 3215, approximately one to four additional 
diagnoses of lung cancer occurred during each of the time periods; no elevation was 
statistically significant.  Lung cancer occurred less often than expected in CT 3216 during 
1982-1986, but more often than expected during the time periods 1987-1992 and 1993-
1998.  In the latter time period the incidence was about as expected.  During 1993-1998, 
this elevation was due to a statistically significant elevation among females in CT 3216 
(16 cases observed vs. 9.1 expected, SIR=176, 95% CI=101-286).  Summaries of lung 
cancer incidence rates by census tract and time period are provided in Tables 12-15. 
VI. EVALUATION OF RISK FACTOR INFORMATION 
As discussed, cancer is a term that describes a variety of individual diseases. 
Epidemiological studies have generally shown that different cancer types have separate 
causes, patterns of incidence, risk factors, characteristics and trends in survival.  
Available risk factor information collected by the MCR related to age distribution as well 
as other factors related to the development of cancer (e.g., gender, smoking status, and 
occupation) was reviewed for individuals diagnosed with leukemia, liver cancer, and lung 
cancer in the city of Marlborough during the time period 1982-2002.   
A. Leukemia  
Leukemia is the general term applied to a group of different cancers, which occur 
in the blood forming organs and result in the formation of abnormal amounts and types of 
white blood cells in the blood and bone marrow.  Individuals with leukemia generally 
maintain abnormally high amounts of leukocytes or white blood cells in their blood.  This 
condition results in an individual’s inability to maintain certain body functions, 
particularly a person’s ability to combat infection. 
In the United States, leukemia occurs at an approximate rate of 9.7/100,000 
persons and accounts for nearly 4% of all cancer deaths (Miller et al. 1996).  While this 
disease occurs most often among whites, it also occurs more often among men than 
women in all racial and ethnic groups (NCI 1996).  In Massachusetts, leukemia 
represents about 2% of all cancers diagnosed each year (ACS 2005). 
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1. Histology (Cell Type) 
There are four main subtypes of leukemia: acute lymphoid leukemia (ALL), acute 
myeloid leukemia (AML), chronic lymphoid leukemia (CLL), and chronic myeloid 
leukemia (CML).  For the purpose of classification in this evaluation, if the histology 
type of the leukemia was not otherwise specified (NOS) or not classified as one of the 
four main subtypes (e.g., prolymphocytic or plasma cell leukemia), then the individual 
case was categorized as “other.”  Available information regarding the expected 
distribution of leukemia by histology types can vary considerably depending on coding 
methods, making comparisons of type-specific incidence rates from different cancer 
registries difficult (Linet and Cartwright 1996).  In the state of Massachusetts during the 
time period 1982-2002, 34% of all leukemia cases were AML, 27% were CLL, 13% were 
ALL, 12% were CML, and 14% were other histology types. 
In Marlborough between 1982-2002, 23% (n=20) of leukemia cases were of the 
CLL type and 14% (n=12) were diagnosed as ALL.  Therefore, a total of 37% of 
individuals diagnosed with leukemia in the city of Marlborough were diagnosed with the 
lymphoid type of the disease.  Myeloid leukemia accounted for 48% of the leukemias 
diagnosed in Marlborough.  Approximately 37% (n=32) of the cases were diagnosed with 
AML and 11% (n=10) of the cases were diagnosed with CML between 1982-2002.  The 
remaining 15% (n=13) of leukemia cases diagnosed in Marlborough were otherwise 
classified or classified as NOS.  In general, the histology distribution of leukemia in 
Marlborough during 1982-2002 was similar to that seen statewide (see Figure 6). 
 
One census tract, CT 3215, had a statistically significant elevation in leukemia 
during the 1982-2002 time period.  The distribution of subtypes for this CT was as 
follows:  Of the 23 individuals diagnosed with leukemia in CT 3215 nine (39%) were 
diagnosed with the AML subtype, six (26%) had the CLL subtype, two (9%) were 
diagnosed ALL, two (9%) were diagnosed with CML and four (17%) were diagnosed 
with a leukemia coded as “other.”  The distribution of histology types in this CT was 
consistent with the statewide experience (e.g., most common subtypes were AML and 
CLL, consistent with state experience).  
 
To assess possible trends over time, the histology distribution was also reviewed 
for each smaller time period evaluated in this report (see Figures 7, 8, 9 and 10).  Based 
on these data, no clear patterns or trends in the incidence of leukemia are indicated with 
respect to histology subtype.  Therefore, overall, it does not appear that the distribution of 
leukemia cases by histology represents an atypical or unexpected pattern. 
2. Gender/Age Distribution 
The four main types of leukemia have notable differences in their age distribution 
(NCI 1996).  While ALL occurs predominantly among children, an elevation in incidence 
is also seen among older individuals. The increase in incidence among older individuals 
begins at approximately 40-50 years of age, peaking at about age 85 (Linet and 
Cartwright 1996).  A similar age breakdown was observed in Marlborough, as ten of the 
12 ALL cases during 1982-2002 were children (0-19 years) and the two other diagnoses 
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of ALL reported were in older individuals (i.e., above age 65).  The occurrence of 
childhood leukemia (ten with ALL histology and one with CML histology) during 1982-
2002 was elevated (11 observed vs. 6.6 expected), with the elevation attributed to a 
statistically significant elevation among male children (9 observed vs. 3.7 expected; 
SIR=243, 95% CI=111-462) (See Table 16).   
 
When evaluated by census tract, the 11 diagnoses of leukemia among children 
during 1982-2002 had the following distribution: one child each in CTs 3211, 3212, 
3213, two children each in CTs 3214, 3215 and four children in CT 3216.  Thus, there 
did not appear to be an unusual distribution of childhood leukemia in any one CT.      
 
CLL rarely occurs before age 30, after which the incidence increases rapidly with 
increasing age.  The majority of CLL diagnoses (i.e., 90%) occur in people over 50 years 
old (Miller et al. 1990).  In Marlborough between 1982-2002, there were 20 individuals 
diagnosed with the CLL histology type reported to the MCR, and all but one of these 
individuals were over the age of 50. 
 
AML presents a trend of increased incidence among people of advancing age.  
This is especially evident at or after age 55, where the incidence of AML increases 
rapidly (LSA 1999a).  Nineteen of the 32 individuals diagnosed with AML in 
Marlborough (59%) were over the age of 55.  The age range of the other 13 individuals 
was between 20 and 54 years of age.  CML can occur at any age, but is most often 
observed in individuals from age 30-50 years old.  Of the ten cases of CML reported in 
Marlborough for the 1982-2002 period, two individuals were between the ages of 30 and 
50 at the time of diagnosis, seven individuals were 55 years of age or older and the 
remaining individual was under the age 30.  Seventy-seven percent (n=10) of the 13 
individuals classified with the leukemia type “other” were over the age of 50. 
 
As mentioned previously, CT 3215 experienced statistically significant elevations 
of leukemia during 1982-2002 time period.  AML and CLL were the two most common 
subtypes in this census tract.  The distribution of ages at diagnosis for individuals with 
AML and CLL in these census tracts was similar to the distribution of ages for AML and 
CLL in the town and state as a whole.  Six of the nine individuals with AML (67%) were 
over the age of 55 and all six individuals with CLL in CT 3215 were over the age of 55.    
 
Leukemia occurs more often among men than women in all racial groups (NCI 
1996).  Rates for all types of leukemia are higher in males than in females.  In 
Marlborough during the 1982-2002 time period, 52% of leukemia diagnoses were male, 
whereas 48% of leukemia diagnoses were female. 
3. Temporal Distribution 
In order to help identify variations in cancer incidence over time, individuals with 
leukemia in Marlborough were examined by their dates of diagnosis.  As shown in Figure 
11, the dates of diagnosis varied throughout the 21-year time period 1982-2002, 
indicating no temporal concentration of diagnoses.  In addition, there was no apparent 
increasing or decreasing trend in the number of diagnoses over time.  In general, within 
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each year, individuals were diagnosed with different subtypes of the disease.  For 
example, among the six individuals who were diagnosed with leukemia in 1996 five 
different leukemia subtypes were diagnosed.  When evaluating the 11 children diagnosed 
with leukemia during 1982-2002, the temporal distribution of diagnoses was as follows:  
one diagnosis each in 1982, 1983, 1992, 1993, 1996, 1997, 1998, 1999, 2000 and two 
diagnoses in 1991.  Thus, there was no apparent temporal concentration of childhood 
leukemia within Marlborough. 
4. Occupation 
Epidemiological research over the past twenty-five years has revealed patterns of 
incidence and risk factors that vary for each subtype of leukemia.  While there are known 
and suspected risk factors for each subtype, leukemia cases are relatively rare, and 
despite a large body of research, risk factors that have been identified for different 
leukemia subtypes only account for a small number of cases (Linet and Cartwright 1996).  
Evaluation of the role of occupation in leukemia in Marlborough is made difficult by the 
large number of recognized leukemia subtypes, only some of which may be associated 
with a specific exposure.  Findings are often inconsistent within a particular industry 
because specific leukemogenic (leukemia causing) exposures have not been identified for 
many occupations (Linet and Cartwright 1996). 
 
Exposure to ionizing radiation is a known environmental risk factor associated 
with the development of ALL.  Few other risk factors for this type of leukemia have been 
identified.  Some studies have identified an increased risk of developing CLL among 
farmers and cigarette smokers, although, findings are conflicting and no specific 
exposure has been clearly identified (Linet and Cartwright 1996).   High dose radiation 
exposure (i.e., nuclear weapon detonation), exposure to benzene, and exposure to 
alkylating agents (e.g., melphalan, cyclophosphamide) have been associated with 
increased risk of developing AML.  Other occupational exposures to solvents such as 
toluene or butadiene in the shoe and rubber industries have not been shown to increase 
leukemia risk (LSA 1999a; NCI 1995; Linet and Cartwright 1996).  Hair dyes have also 
been investigated extensively without a conclusive risk demonstrated.  Other professions 
that have been associated with an increased risk of AML include embalmers, anatomists, 
pathologists and nurses handling antineoplastic drugs.  Some associations have also been 
observed in metal mill, aluminum, and foundry workers.  The only known environmental 
risk factor for CML is exposure to ionizing radiation (based on studies of atomic bomb 
survivors). 
 
Occupation as reported to the MCR at the time of diagnosis was reviewed for 
each individual diagnosed with leukemia in Marlborough.  Of the 87 individuals 
diagnosed with leukemia during 1982-2002, 11 were children and therefore did not have 
occupations.  Review of this information for adults revealed occupations that for the most 
part, are not thought to be associated with the development of leukemia.  However, the 
occupational data reported to the MCR are limited to job title and do not include specific-
job duty information that could further define exposure potential for individual cases.  Of 
the 76 adults diagnosed with leukemia in Marlborough during 1982-2002, occupational 
information reported to the MCR was listed as “unknown,” “retired,” or “homemaker” 
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for 32 (42%) of the individuals.  Three out of 76 individuals (4%) reported occupations in 
which exposure to solvents (i.e., benzene) or ionizing radiation may have been possible, 
but without more specific job duty information it is difficult to assess the role their 
occupation may have played in the development of their leukemia. 
5. Other Risk Factors 
Each of the four main types of leukemia has genetic and unique risk factors 
associated with them.  There is evidence that genetics may have a role in the development 
of ALL.  Studies indicate that if one of a pair of homozygotic (identical) twins is 
diagnosed with leukemia, the other twin, who has the same genetic makeup, is at 
increased risk of developing the disease (Schuz et al. 1999).  Children diagnosed with 
chromosome disorders such as Down syndrome and Bloom’s syndrome are also at an 
increased risk of developing ALL (Linet and Cartwright 1996).  Genetics, viruses, and 
diseases of the immune system have been suggested as playing a role in the development 
of CLL.  It is thought that individuals with a family history of CLL are three times as 
likely to develop the disease (LSA 1999b).  Congenital disorders and genetic factors have 
also been associated with the development AML.  Bloom’s syndrome has been observed 
among older individuals diagnosed with AML.  Klinefelter’s syndrome has also been 
identified among individuals diagnosed with this disease (Linet and Cartwright 1996).  
One of the only known risk factors for CML besides ionizing radiation is chromosome 
abnormalities such as the Philadelphia chromosome (Golde and Guliti 1994; Higgenson 
et al. 1992).  Among individuals diagnosed with CML, more than 90% are identified as 
having this unique chromosome disorder (NCI 1995).  It should be noted that family 
histories and/or medical records of individuals diagnosed with leukemia in Marlborough 
were not available in this cancer assessment and therefore could not be evaluated. 
 
Finally, patients who are treated with radiation therapy and/or chemotherapy for 
other cancers have a slight risk of developing secondary leukemia (especially AML) later 
in life.  Review of data from the MCR identified eight individuals (9%) diagnosed with 
leukemia in Marlborough during 1982-2002 who had been previously diagnosed with a 
different primary site cancer.  These patients may have received treatment that could have 
contributed to their subsequent leukemia diagnosis.  Again, because medical records were 
not available, it was not possible to determine whether these individuals actually received 
radiation therapy or chemotherapy for their cancer. 
6. Residential History 
Cancer in general has a long period of development or latency period (i.e., the 
interval between first exposure to a disease-causing agent and the appearance of 
symptoms of the disease [Last 1995]) that can range from 10 to 30 years and in some 
cases may be more than 40 to 50 years for solid tumors (Bang 1996; Frumkin 1995).  
However, the latency period for hematologic malignancies (i.e., cancers of the blood or 
bone marrow) is in the range of 4 to 5 years (Frumkin 1995).  Although it is not possible 
to determine what may have caused any one person’s diagnosis with cancer, the length of 
time in which an individual lived in a particular residence can help determine the 
importance that their location might have in terms of exposure to a potential 
  17
environmental source.  Therefore, residential histories were constructed for Marlborough 
residents diagnosed with leukemia in order to determine how long they resided in their 
residence prior to diagnosis.  Because shorter periods of residence can represent a 
significant portion of a child’s life, residential histories for children ages 0-19 were 
evaluated separately.  Information for residential histories was obtained from annual 
resident lists for the city of Marlborough (City of Marlborough 1970-2001). 
 
Based on the information reviewed for the 76 adults diagnosed with leukemia in 
Marlborough between 1982-2002, 63% (n=48) had lived at their address five or more 
years prior to diagnosis and 20% (n=15) had lived at their address for less than five years 
prior to diagnosis.  Residential histories could not be confirmed for 17% (n=13) of the 
individuals and therefore these individuals likely only lived at their address for a short 
time (e.g., less than one year) prior to diagnosis. 
 
Residents of CT 3215 experienced a statistically significant elevation in the 
incidence of leukemia during the 21-year time period 1982-2002.  Of the 23 adults 
diagnosed in this CT, 57% (n=13) lived at their reported address for at least five years 
prior to diagnosis.  Five individuals had lived at their address for less than five years prior 
to diagnosis.  Residential histories could not be confirmed for five individuals in CT 
3215. 
 
Between 1982-2002, 11 children ages 0-19 were diagnosed with leukemia in 
Marlborough.  Based on a surname search of Marlborough resident lists, three of these 
children appeared to have lived at their reported address since birth and four school-aged 
children had lived at their reported address at least since they were toddlers.  The families 
of the remaining four children could not be identified in city resident lists indicating that 
these families likely only lived at their address for a short time prior to the child’s 
leukemia diagnosis. 
B. Liver Cancer 
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver 
(El-Serag and Mason 1999).  HCC occurs most frequently in Asia, Africa and the 
Mediterranean basin (Akrividas et al. 1998).  Liver cancer rates can vary substantially by 
country and although more than 80% of liver cancer cases occur in the developing world, 
incidence is rapidly increasing in the United States (Stuver 1998; Ince and Wands 1999). 
1. Gender/Age Distribution 
In the United States, men are more likely than women to develop HCC and blacks 
are affected twice as often as whites (El-Serag and Mason 1999).  Although the risk of 
developing HCC increases with increasing age, the disease can occur in persons of any 
age.  The median age of individuals diagnosed with liver cancer in Marlborough between 
1982-2002 was 69 years old.  Ninety-six percent of the cases (n=27) were greater than 50 
years old at the time of diagnosis.  In Marlborough, eighteen males and ten females were 
diagnosed with liver cancer between 1982-2002.   
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During the 21-year time period 1982-2002 in census tract 3213, where a 
statistically significant elevation in liver cancer was observed, seven of the nine 
individuals were over the age of 70.  Five individuals were male and four were females.  
Between 1982-2002, in CT 3214, the location of the Glen Street area, one male over age 
70 was diagnosed with liver cancer.   
2. Personal Risk Factors 
Chronic infection with the hepatitis B virus (HBV) and hepatitis C virus (HCV) 
are major risk factors for developing HCC (Fattovich 1998).  In fact, scientists estimate 
that 10 to 20% of people infected with HBV will develop cancer of the liver.  HBV is 
very common in Africa, China, and the Middle East.  It has been estimated that 
approximately 4 million persons in the United States have chronic HCV infection (Ince 
and Wands 1999).  Risk factors for the transmission of HBV and HCV include 
intravenous drug use, sharing of needles, unsafe sexual practices and transfusion of and 
contact with unscreened blood and blood products (El-Serag and Mason 1999).  In 
addition, mothers who are infected with these viruses can pass them on to their children. 
 
In addition, numerous epidemiological studies have identified chronic alcohol 
consumption as a significant risk factor associated with liver cancer (Seitz et al. 1998).  
Although alcohol is not a carcinogen itself, laboratory studies have shown that it may act 
as a cocarcinogen in the development of HCC (El-Serag and Mason 1999).  Some studies 
have suggested that alcohol and chronic HCV infection may act in concert with one 
another to accelerate liver disease and damage.  One study conducted in Italy showed that 
people with alcoholism and HCV infection often developed liver disease, which was 
followed by cirrhosis and the development of HCC (Bellantani et al. 1994). 
 
Cirrhosis is perhaps the most important risk factor related to the development of 
HCC.  Cirrhosis is a progressive disease, which causes inflammation and scar tissue to 
form on the liver.  Scientists have estimated that 70 to 90% of individuals diagnosed with 
HCC also have cirrhosis (Johnson 1996). Other risk factors associated with the 
development of HCC such as alcoholism and HBV and HCV infection also cause 
cirrhosis.  Personal risk factor information was not available for individuals diagnosed 
with liver cancer in Marlborough and was therefore not evaluated in this report. 
3. Occupation 
Additional risk factors related to the development of liver cancer include long-
term exposure to aflatoxins, vinyl chloride, and thorium dioxide.  Aflatoxins are 
carcinogenic agents produced by a fungus found in tropical and subtropical regions.  
Individuals may be exposed to aflatoxins if they consume peanuts and meal that have 
been stored under hot, humid conditions (Bellantani et al. 1994).  Vinyl chloride has been 
primarily used in the United States to make polyvinyl chloride (PVC), which is used to 
make a variety of plastic consumer products and home furnishings (ATSDR 1997).  
Vinyl chloride is a known human carcinogen and occupational exposure to this chemical 
has been associated with the development of a specific type of liver cancer called 
angiosarcoma.  Radioactive thorium dioxide was widely used in clinical medicine as a 
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diagnostic agent in Europe and Japan until 1950.  Research has shown that fifteen years 
following exposure, the development of cirrhosis and HCC occurred in individuals who 
were exposed to this compound (Bellantani et al. 1994).  The impact of both thorium 
dioxide and vinyl chloride was much greater in the past, since thorium dioxide has not 
been used for decades and exposure of workers to vinyl chloride is now regulated (ACS 
1999).  However, given the lengthy latency (development) period for most cancer types 
(i.e., 20 or more years), it is possible that individuals diagnosed with liver cancer during 
the 1980s and 1990s, consistent with the time period evaluated in this report, could have 
had an occupational exposure that contributed to their disease.  Finally, liver cancer has 
also been associated with exposure to arsenic, DDT, and dieldrin.  Large-scale 
epidemiological studies have shown an association between arsenic and liver cancer 
while several animal studies have shown that DDT and dieldrin causes liver cancer in 
mice and rats (ASTDR 1993a, 1993b, and 1994).  
 
Of the 28 individuals diagnosed with liver cancer in Marlborough between 1982-
2002, occupation was reported as “retired” or “unknown” for 36% (n=10).  Review of 
occupational information for the remaining individuals did not indicate any jobs that have 
been associated with the development of liver cancer.  However, occupational 
information reported to the MCR is limited to job title and does not contain specific job 
duty information that would provide a better indication of potential exposures.  In 
addition, occupational information as reported to the MCR is not historical, that is, 
information regarding former occupations that may have been associated with potential 
exposures is not included. 
C. Lung Cancer 
Lung cancer generally arises in the epithelial tissue of the lung.  Several different 
histologic or cell types of lung cancer have been observed.  The various types of lung 
cancer occur in different regions of the lung and each type is associated with slightly 
different risk factors, although smoking is the primary risk factor for all types of lung 
cancer (Blot and Fraumeni 1996).  The most common type of lung cancer in the United 
States today is adenocarcinoma (Thun et al. 1997). 
1. Gender/Age Distribution 
The incidence of lung cancer increases sharply with age peaking at about age 60 
or 70.  Only two percent of lung cancers occur before the age of 40.  Lung cancer 
incidence is greater among men than women and greater among blacks than whites.  The 
highest rates of lung cancer have been reported among urban black men (Blot and 
Fraumeni 1996).  Trends in lung cancer incidence have revealed that the disease has 
become increasingly associated with populations of lower socioeconomic status, since 
these individuals may be more likely to be smokers (Blot and Fraumeni 1996). 
 
In Marlborough during 1982-2002, less than one percent of individuals diagnosed 
with lung cancer were diagnosed before the age of 40.  The mean age of individuals 
diagnosed with lung cancer in Marlborough during this time period was 68 years old.  
The majority of individuals (93%) were age 50 years or older at the time of diagnosis.  In 
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Marlborough, 263 males and 174 females were diagnosed with lung cancer between 
1982-2002. Lung cancer was statistically significantly elevated among males when 
compared with statewide cancer incidence. 
 
In CT 3213, where a statistically significant elevation was observed among males, 
65 males were diagnosed with lung cancer between 1982-2002, compared to 
approximately 45 expected diagnoses.  The mean age of males diagnosed with lung 
cancer in this census tract was approximately 70 years. 
 
In CT 3214, where the Glen Street neighborhood is located, among the 41 
individuals diagnosed with lung cancer during 1982-2002, 23 were males and 18 were 
females.  The average age of diagnosis was 67 years. 
2. Smoking Status 
Smoking is the most important known risk factor associated with the development 
of lung cancer.  In 1985, an estimated 90% of lung cancer cases among men and 79% 
among women were attributed to cigarette smoking (Blot and Fraumeni 1996).  More 
recently, an increase in cigarette smoking among women has produced lung cancer 
incidence rates that more closely resemble those experienced by males.  The risk of 
developing lung cancer depends on the intensity of one’s smoking habits (i.e., duration of 
habit, amount smoked, tar yield of cigarette, and filter type).  Further, this risk declines 
after smoking cessation.  However, investigators estimate it can take ten to twenty years 
of not smoking for long term, heavy smokers to reduce their risk of developing lung 
cancer.  Studies suggest that the risk for developing lung cancer will always be about 
twice as high for ex-smokers compared to non-smokers (Blot and Fraumeni 1996).  In 
Massachusetts as a whole, 78% of individuals diagnosed with lung cancer during 1982-
2002 were current or former smokers at the time of diagnosis, 7% were non-smokers, and 
smoking history was unknown for the remaining 15% of individuals. 
 
Information regarding smoking status as reported to the MCR was reviewed for 
individuals in Marlborough diagnosed with lung cancer.  A total of 437 individuals were 
diagnosed with cancer of the lung in Marlborough between 1982-2002.  Trends in 
smoking history for these individuals were consistent with those observed statewide.  In 
Marlborough, approximately 80% (n=350) of individuals diagnosed with lung cancer 
during 1982-2002 reported being current or former smokers at the time of diagnosis 
while 6% (n=25) reported being non-smokers.  Smoking status was unknown for 
approximately 14% (n=62) of the cases (see Figure 12).  Therefore, of those for whom 
smoking status was known (n=375), approximately 93% (n=350) reported their smoking 
status as a current or former smoker and 7% (n=25) reported that they never smoked. 
 
A total of 65 lung cancer cases were diagnosed among males in CT 3213, where a 
statistically significant elevation was observed between 1982-2002.  Approximately 83% 
of these individuals reported being current or former smokers at the time of diagnosis, 
6% were non-smokers, and smoking status was unknown for 11% of individuals (see 
Figure 13). 
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In CT 3214, where the Glen Street neighborhood is located, 73% of the 
individuals diagnosed with lung cancer between 1982-2002 reported being current or 
former smokers at the time of diagnosis, 15% were non-smokers, and smoking status was 
unknown for 12% of the individuals. 
3. Occupation 
Occupational exposure has also been identified as playing a role in the 
development of lung cancer.  Occupations such as underground miners, chemical 
workers, paper and pulp workers, carpenters, butchers and meat packers, and shipyard 
workers are some of the occupations associated with increased risk of developing this 
cancer type.  This is a result of exposure to chemical compounds that may be found in 
such workplaces such as arsenic, asbestos, chloromethyl ethers, chromium, vinyl 
chloride, and ionizing radiation.  In addition, the occupational exposure to such 
compounds in conjunction with cigarette smoking dramatically increases the risk of 
developing lung cancer (Blot and Fraumeni 1996). 
 
Exposure to radon (a naturally occurring gas produced by the breakdown of 
radium and uranium) has been associated with increased risk of developing lung cancer 
(Blot and Fraumeni 1996).  Exposure to radon gas by underground miners is recognized 
to cause lung cancer.  Risk projections in a number of studies suggest that radon is the 
second leading cause of lung cancer after smoking (Samet and Eradze 2000). 
Occupation as reported to the MCR at the time of diagnosis was reviewed for 
each individual diagnosed with lung cancer in Marlborough.  Review of this information 
revealed occupations that for the most part, are not thought to be associated with the 
development of lung cancer.  However, between 1982-2002, 32 individuals (7%) reported 
occupations where exposure to lung cancer carcinogens may have been possible.  Of 
note, the occupational data reported to the MCR are limited to job title and do not include 
specific-job duty information that could further define exposure potential for individual 
cases.  In addition, occupational information reported to the MCR was reported as 
“retired,” “at home,” or “unknown” for approximately 33% of the individuals (n=143) 
diagnosed with lung cancer in Marlborough during the 21-year time period 1982-2002.  
For these reasons it is not possible to evaluate the degree to which these individuals’ 
occupations may have contributed to the elevated lung cancer incidence rates in 
Marlborough.  However, based on the information reviewed, it is plausible that 
occupation may have played a role in the development of lung cancer among at least 
some residents of Marlborough during the period of 1982-2002. 
VII. GEOGRAPHIC DISTRIBUTION 
In addition to quantitatively determining the census tract-specific incidence ratios 
for leukemia, liver cancer, and lung cancer, a qualitative evaluation was conducted to 
determine whether individuals with these cancer types appeared to be geographically 
concentrated in some area(s) within any of the six census tracts in Marlborough.  Place of 
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residence at the time of cancer diagnosis was geocoded or mapped using a geographic 
information system (GIS), to assess any possible geographic concentration of diagnoses.  
As previously mentioned, cancer is one word that describes many different diseases.  
Therefore, for the purposes of this evaluation, the geographic distribution of each cancer 
type was evaluated separately to determine whether an atypical pattern of any one type 
occurred.  For confidentiality reasons, maps of the location of individuals diagnosed with 
cancer cannot be provided in this report.  However, as described below, review of this 
information did not reveal any unusual spatial patterns or geographic concentrations of 
diagnoses in Marlborough that could not be attributed to such factors as increased 
population density. 
A. Leukemia 
During 1982-2002, leukemia was elevated in five of the six CTs in Marlborough, 
with CT 3215 having a statistically significantly elevated rate.  The spatial distribution of 
leukemia within the CTs was reviewed.  A large number of individuals with leukemia in 
CT 3215 were located in or near the center of Marlborough.  There is a direct correlation 
between population density and the geographic distribution of leukemia cases observed in 
this census tract.  In addition, no specific concentration of cases by subtype was apparent 
among these individuals that would suggest a common environmental factor was related 
to their diagnosis.  No unusual geographic patterns or concentrations of individuals with 
leukemia were observed in CT 3214 in the Glen Street neighborhood or near the former 
orchard area. 
When evaluating leukemia in a geographic context, it is important to examine the 
location of cases by type of leukemia.  The four main types of leukemia each have their 
own unique etiologies (or causes) and/or risk factors, some of which are understood 
better than others.  As discussed previously, there are four main types of leukemia: CLL, 
ALL, AML, and CML.  The most common type of leukemia diagnosed in Marlborough 
during 1982-2002 was AML, which represented 37% of all leukemia diagnoses (n=32).  
Again, the majority of individuals diagnosed with AML were located in or near the center 
of Marlborough, but no specific concentration of these individuals was evident.  Overall 
there were ten (11%) individuals with CML in Marlborough during 1982-2002, 
distributed fairly evenly throughout the city.  Of these, two resided in CT 3214, including 
one in the Glen Street neighborhood.  None of the individuals with CML were located in 
close proximity to one another. 
The second most common type of leukemia diagnosed in Marlborough during 
1982-2002 was CLL (23%, n=20).  A small concentration of approximately seven 
individuals diagnosed with CLL was observed in the center of Marlborough.  In addition 
to higher population density in this area of the city, these individuals were diagnosed in 
different years, indicating that these cases were not concentrated over time, and all of the 
individuals were 65 or older, as expected for this type of leukemia.  Individuals 
diagnosed with this type of leukemia who did not live near the center of the city (i.e., in 
CTs 3211, 3212, and 3214) were not located in close proximity to each other. 
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ALL is typically diagnosed among children and people of older age groups (i.e., 
age 50 and older).  The majority of individuals diagnosed with ALL in Marlborough 
during 1982-2002 (ten children and two older adults) lived in and around the center of the 
city at the time of diagnosis.  Again, this is a high-density residential area and the 
observed pattern of a greater number of cases in this area is not unexpected.  Two 
children diagnosed with ALL during 1982-2002 were within close proximity of one 
another in CT 3214.  These individuals did not reside near the Glen Street neighborhood 
and the dates of diagnosis for these individuals differed by more than six years. 
During 1982-2002, there were 13 individuals (15%) with types of leukemia that 
could not be classified into one of the four major subtypes either because they were 
otherwise classified or classified as NOS.  Although these leukemia types do not likely 
share a common etiology, individuals who were diagnosed as “other” were still reviewed 
geographically.  The residence of these individuals did not exhibit any unusual 
geographic patterns within the city. 
B. Liver Cancer 
Of the 28 individuals diagnosed with liver cancer between 1982-2002 in 
Marlborough, the majority lived in or near the center of the city.  In CT 3213, where a 
statistically significant elevation of liver cancer was observed, all nine of the individuals 
diagnosed were located in the northern portion of the census tract.  This area of CT 3213 
is more densely populated and has a number of multi-unit housing complexes, where 
some individuals resided at the time of diagnosis, and likely contributes to the great 
number of cases in this area of the census tract.  The dates of diagnosis for these 
individuals varied throughout the 21-year time period, indicating no temporal pattern of 
diagnoses over time and seven of the nine individuals were over the age of 70.  In CT 
3214, one person was diagnosed with liver cancer.  The individual resided in the northern 
portion of the census tract, which is not located near the former orchard property or the 
Glen Street neighborhood.  No other geographic concentrations of liver cancer diagnoses 
were observed during the 1982-2002 time period. 
C. Lung Cancer 
No unusual geographic pattern of lung cancer was observed in the city of 
Marlborough or within any of the six census tracts during the 21-year time period 
evaluated 1982-2002.  In census tracts where cases appeared to be geographically 
concentrated, further evaluation showed that the concentrations were located in areas of 
dense population or were likely explained by the presence of multi-unit housing 
complexes.  No unusual geographic pattern of lung cancer was observed within CT 3214 
or near the Glen Street neighborhood and/or the former orchard area.  Finally, review of 
non-smokers diagnosed with lung cancer revealed no apparent spatial concentrations of 
cases. 
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VIII. CANCER INCIDENCE IN THE GLEN STREET NEIGHBORHOOD 
To address concerns over a suspected elevation of cancer in the Glen Street 
neighborhood in Marlborough, MA (see Figure 2), a review of MCR data for residents of 
this area who had been diagnosed with any cancer type since 1982 was conducted.  In 
general, our review found no atypical pattern of cancer in the Glen Street neighborhood.  
Between 1982 and the present (as of May 12, 2006), a total of 50 cancer diagnoses were 
reported to the MCR among 45 residents of the Glen Street area roughly bounded by 
Glen Street and MacKay Drive to the west, Interstate 495 to the east, Forest Street to the 
south, and Mount Royal Avenue to the north (some individuals had more than one cancer 
diagnosis).  Eighteen different types of cancer were diagnosed among residents, 
indicating the occurrence of many different diseases.  The most commonly reported 
diagnoses included cancers of the lung and bronchus, breast, prostate, and colon/rectum, 
which is consistent with national and statewide trends in cancer incidence.  Together, 
these cancer types represented more than half (56%) of the cancer diagnoses in this area.  
Other types of cancer included bladder cancer, kidney cancer, multiple myeloma, 
laryngeal cancer, oral cavity and pharynx cancer, brain and central nervous system (CNS) 
cancer, leukemia, melanoma, cervical cancer, ovarian cancer and other rare types.  There 
was no specific temporal pattern or geographic concentration of any one cancer type.  
That is, diagnoses did not appear “clustered” in time or space within the Glen Street 
neighborhood.  The years of diagnosis for these individuals varied throughout the 22 
years reviewed. 
 
The majority of cancer types diagnosed among residents of the Glen Street 
neighborhood are predominantly associated with non-environmental factors such as 
family history, smoking, diet, and other lifestyle behaviors.  Because the MCR collects 
some information related to risk factors (e.g., smoking history) for individuals diagnosed 
with cancer, to better characterize the incidence patterns of cancer in this area of 
Marlborough, the available data on risk factors from the MCR for individuals diagnosed 
with cancer in the Glen Street neighborhood was reviewed (e.g., age at diagnosis, gender, 
smoking history, and occupation). 
 
Age is an important risk factor in many cancers.  Different cancers occur with 
different frequencies among the various age groups, and most cancer types occur more 
frequently in older populations (i.e., age 50 and over).  The average age at diagnosis 
among individuals in the Glen Street neighborhood was 61 and the majority of diagnoses 
(86%) occurred among individuals aged 50 or older at the time of diagnosis.  Half of the 
individuals were male (n=25).  Review of information regarding age and gender indicates 
that the incidence of cancer in this area is generally consistent with established 
prevalence patterns of disease in the general population. 
 
Because cigarette smoking is an important risk factor in the development of 
several cancer types, including cancers of the lung and bronchus, oral cavity and pharynx, 
larynx, bladder, kidney, and colon/rectum, smoking history was also reviewed for each 
individual in the Glen Street neighborhood who had been diagnosed with these diseases.  
Of the 24 individuals with a smoking-related cancer, 19 (79%) reported being current or 
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former smokers at the time of diagnosis, four were non-smokers, and smoking history 
was unknown for one individual.  Therefore, it is likely that smoking played an important 
role in the development of cancer among some residents of the Glen Street neighborhood. 
 
Finally, some occupational exposures, such as in jobs involving contact with 
chemicals, have also been associated with an increased risk for developing certain types 
of cancer.  While the MCR data available for occupation are limited (i.e., the occupation 
is often listed too generally as the name of a business or as retired), a review of 
occupation as reported to the MCR was conducted.  Review of this information showed 
that one individual in this area of Marlborough worked in a job where exposures that 
could be related to an increased risk for developing their cancer may have been possible.  
None of the information available for any other residents diagnosed with cancer 
suggested that exposures at work were likely related to their development of cancer.  It is 
probably also important to mention that the information reported to the MCR is based on 
occupation at the time of diagnosis and therefore potential exposures associated with past 
occupations cannot be determined.  Occupation was reported as retired, at home, or 
unknown for 25% of the individuals diagnosed with cancer in the Glen Street 
neighborhood. 
IX. COMMUNITY ENVIRONMENTAL CONCERNS 
In addition to reviewing environmental data for the former apple orchard in 
Marlborough, discussed separately in the Public Health Assessments (MDPH 2000; 
MDPH 2006), information regarding other potential environmental sources located in 
Marlborough and listed with the Massachusetts Department of Environmental Protection 
(MDEP) was reviewed (MDEP 2001a, 2001b, and 2002a).  Under Chapter 21E of the 
Massachusetts General Laws (also known as the State Superfund), which was enacted in 
1983, the MDEP investigates potentially hazardous waste sites in the state and conducts 
and oversees cleanup of these sites.  The locations of sites in the BWSC database were 
mapped and evaluated in relation to the places of residence of individuals diagnosed with 
cancer in Marlborough between 1982 and 2002. 
 
Although the Massachusetts General Laws require that MDEP be notified of 
contamination that exceeds specified levels, it is important to note that chemical 
concentrations detected in environmental media do not necessarily represent a health 
threat.  In order for a compound to impact one’s health, it must not only be present in a 
certain environmental media but one must also come into contact with the compound via 
the contaminated media (e.g., through ingestion, inhalation, or skin absorption).  
Therefore, the presence of contaminants at a site alone does not necessarily indicate a 
potential health impact to nearby residents.  However, the pattern of individuals 
diagnosed with leukemia, liver cancer, and lung cancer in Marlborough in proximity to 
these sites may indicate that an environmental factor could be related to the incidence of 
these cancer types in Marlborough. 
 
A summary of the 21E sites in Marlborough reported to MDEP from 1983 to 
2002 is presented in Table 17.  A total of 353 environmental releases or spills have been 
reported to MDEP under the State Superfund program.  However, as shown in Table 17, 
  26
multiple releases were reported at some sites.  Approximately 22% (n=77) of sites 
reported to MDEP during this time period did not have sufficient address information to 
allow for mapping of the site location.  Of all the reported releases during this time 
period, 60% involved petroleum-related chemicals (e.g., oils, fuels, gasoline), 25% of 
sites involved other chemicals (e.g., metals, organic compounds, pesticides), and the type 
of material was unknown for 15% of the releases. 
X. DISCUSSION 
While statistically significant elevations were noted in the incidence of leukemia, 
liver cancer, and lung cancer during the period 1982-2002 in the city of Marlborough and 
in some individual census tracts, these elevations did not persist into the most recent time 
period (1999-2002) for any of the cancer types investigated, which all occurred about as 
expected for the city as a whole.  Review of available risk factor information from the 
MCR for individuals diagnosed with these cancer types in Marlborough suggests that the 
patterns of these three cancers with respect to age and gender are consistent with trends in 
the general population.  It also appears that smoking likely played an important role in the 
incidence of lung cancer in Marlborough during 1982-2002 (93% of those with a known 
smoking history were current or former smokers).  In addition, it is possible that 
occupational exposures may have contributed to the development of leukemia and lung 
cancer among some individuals in Marlborough. 
Childhood leukemia was also statistically significantly elevated among males in 
Marlborough during 1982-2002.  When evaluating childhood cancer during 1982-2002, 
all male children were diagnosed with the most common type for children (ALL) and the 
geographic distribution of individuals did not indicate an unusual pattern (i.e., diagnoses 
spread throughout five of the six CTs of Marlborough).  Also, a review of residential 
history indicated that four of the nine children likely had recently moved to Marlborough, 
suggesting that residence in Marlborough was not likely to have played a role in their 
diagnosis.  The 11 diagnoses of leukemia among children were also spread over the entire 
time period with no temporal concentration within Marlborough.  Thus, all their 
information together does not suggest a common factor, environmental or otherwise, 
played a role in these childhood leukemia diagnoses.   
Analysis of the geographic distribution of residences of individuals diagnosed 
with leukemia, liver cancer, or lung cancer during 1982-2002 did not reveal any atypical 
spatial patterns of cancer.  Specifically, the distribution of diagnoses seemed to coincide 
closely with the pattern of the population in Marlborough.  Additionally, because 
members of the community had voiced particular concerns regarding the Glen Street 
neighborhood and the former apple orchard area (both located in CT 3214), the pattern of 
cancer incidence for this area was specifically reviewed.  In CT 3214 between 1982-
2002, leukemia and cancers of the lung and liver occurred approximately at expected 
rates when compared to statewide incidences for those cancer types.  A review of the 
geographic distribution of individuals diagnosed with these cancer types did not reveal 
any unexpected spatial patterns or other concentration of diagnoses in CT 3214 near or in 
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the Glen Street neighborhood or near the former apple orchard property during the 21-
year time period evaluated 1982-2002.   
Finally, several chemical contaminants (i.e., pesticides) were detected at the 
former apple orchard, some of which have been associated with an increased risk of liver 
cancer (i.e., arsenic, DDT, and dieldrin) and lung cancer (i.e., arsenic).  However, it is 
unlikely that exposure to these compounds by residents of the Glen Street neighborhood 
or the surrounding area would have resulted in adverse health effects (including cancer) 
based on the concentrations detected and estimated exposure opportunities (MDPH 
2000).  As discussed above, the incidence of leukemia, liver cancer, and lung cancer was 
about as expected in CT 3214 between 1982-2002 and no unusual concentrations of 
diagnoses were observed in the area surrounding the former orchard or any other part of 
the census tract, lending further support to the conclusion that environmental factors were 
not likely to have played a major role in the pattern of these cancer types in this area of 
Marlborough. 
XI. LIMITATIONS 
This investigation considers descriptive health outcome data for cancer to 
determine whether the pattern or occurrence of selected cancers is unusual.  The purpose 
of this investigation was to evaluate the patterns of cancer in a geographical context in 
relation to available information about factors, including environmental factors, related to 
cancer to see whether further investigation seems warranted.  Information from 
descriptive analyses, which may suggest that a common etiology (or cause) is possible, 
can serve to identify areas where further public health actions may be warranted.  
Inherent limitations in this type of analysis and the available data make it impossible to 
determine the precise causal relationships or synergistic roles that may have played a part 
in the development of individual cancers in this community.  Also, this type of analysis 
cannot determine what may have caused cancer in any one individual.  Cancers in general 
have a variety of risk factors known or suggested to be related to the etiology (cause) of 
the disease that could not be evaluated in this report.  It is believed that many types of 
cancers are related largely to behavioral factors such as cigarette smoking, diet, and 
alcohol consumption.  Other factors associated with cancer are socioeconomic status, 
heredity/genetics, race, and geography.  It is beyond the scope of this report to determine 
the causal relationship of these factors and the development of cancer or other health 
outcomes in Marlborough. 
XII. CONCLUSIONS 
• Review of the available case information, environmental data, and geographic pattern 
of diagnoses does not suggest that a common factor (environmental or non-
environmental) is likely related to these diagnoses. 
• With respect to the Glen Street area and surrounding orchard property, there were no 
unusual patterns of cancer observed.  During the 21-year time period 1982-2002, one 
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individual was diagnosed with liver cancer in CT 3214, where Glen Street is located; 
however, this individual did not reside near the area of concern.  During the time 
period 1982-2002, leukemia and lung cancer both occurred at about the levels 
expected in CT 3214, and neither of these cancer types was unusually concentrated 
anywhere within this census tract.   
• Leukemia was statistically significantly elevated citywide in Marlborough and in CT 
3215 during 1982-2002.  Leukemia diagnoses in Marlborough were of all different 
subtypes and review of the histology distribution did not reveal any atypical or 
unexpected patterns.  The majority of individuals with leukemia in Marlborough were 
located close to the center of Marlborough, which is the most densely populated area 
in the city.  No unusual patterns were observed when leukemia was evaluated by 
subtype with respect to geographic location.  In addition, diagnoses of leukemia were 
spread across the 1982-2002 period with no increasing or decreasing trend. 
• Although the rate of childhood leukemia among males was statistically significantly 
elevated in Marlborough during the 1982-2002 time period evaluated, available 
information on histology, geographic distribution, temporal distribution, and 
residential history does not suggest a common factor played an important role in this 
elevation. 
• Review of available risk factor information related to lung cancer incidence in the 
city of Marlborough between 1982-2002 suggests that cigarette smoking likely played 
a role in the statistically significantly elevated rate of lung cancer citywide. 
• The information reviewed indicates that occupational exposures may have been a 
potential factor in the development of leukemia and lung cancer among some 
individuals during the 21-year time period 1982-2002.  However, information on 
occupation reported to the MCR is generally too limited to evaluate the actual role it 
may have played in areas where increased leukemia and lung cancer rates were 
observed. 
• Review of MCR data for residents of the Glen Street neighborhood diagnosed with 
any cancer type between 1982 and the present revealed no atypical pattern of cancer 
in this area.  Eighteen different types of cancer were diagnosed among residents of 
this neighborhood, indicating the occurrence of many different diseases.  In general, 
the patterns observed were consistent with national and statewide trends in cancer 
incidence. 
XIII. RECOMMENDATIONS 
• Although elevations were noted in the incidence of leukemia, liver and lung cancer in 
Marlborough during 1982-2002, based on the information reviewed, no specific 
pattern of these cancers emerged that suggests a common environmental factor is 
likely related to the incidence of these cancers.  Therefore, the MDPH recommends 
no further investigation of cancer in Marlborough at this time.  The MDPH/CEH will 
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continue to monitor the incidence of leukemia, liver cancer, and lung cancer in 
Marlborough through the city/town cancer incidence reports published by the 
Massachusetts Cancer Registry. 
• If requested, the CEH’s Environmental Health Education Program will work with the 
Marlborough Board of Health and the community to provide educational information 
and conduct outreach activities to Marlborough residents about ways to reduce their 
risk of cancer. 
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Figure 3:  Incidence of Leukemia Diagnoses in Marlborough Census Tracts 
1982-1986
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Figure 4:  Incidence of Liver Cancer Diagnoses in Marlborough Census Tracts
1982-1986
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Figure 5:  Incidence of Lung Cancer Diagnoses in Marlborough Census Tracts 
1982-1986
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Figure 6
Distribution of Leukemia Subtype Among Individuals Diagnosed with Leukemia
Marlborough, MA
1982-2002
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Figure 7
Distribution of Leukemia Subtype Among Individuals Diagnosed with Leukemia
Marlborough, MA
1982-1986
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Figure 8
Distribution of Leukemia Subtype Among Individuals Diagnosed with Leukemia
Marlborough, MA
1987-1992
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Figure 9
Distribution of Leukemia Subtype Among Individuals Diagnosed with Leukemia
Marlborough, MA
1993-1998
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Figure 10
Distribution of Leukemia Subtype Among Individuals Diagnosed with Leukemia
Marlborough, MA
1999-2002
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Figure 11
Distribution of Year of Diagnosis Among Individuals Diagnosed with Leukemia
Marlborough, MA
1982-2002
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Figure 12
Smoking History Among Individuals Diagnosed with Lung Cancer in Marlborough, MA
1982-2002
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Figure 13
Smoking History Among Males Diagnosed with Lung Cancer in Marlborough CT 3213
1982-2002
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TABLES 
 
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 12 8.6 140 72 -- 244 5.0 4.8 104 34 -- 243 7 4.3 163 65 -- 335
3212 14 11.0 127 70 -- 214 9.0 6.1 148 67 -- 280 5 4.8 104 34 -- 243
3213 18 11.9 151 90 -- 239 11.0 6.6 167 83 -- 298 7 5.4 130 52 -- 267
3214 5 5.6 89 29 -- 208 2.0 3.0 NC NC -- NC 3 2.5 NC NC -- NC
3215 23 11.7 197 * 125 -- 295 10.0 6.2 161 77 -- 297 13 5.5 236 * 126 -- 404
3216 15 10.7 140 78 -- 231 8.0 6.2 129 56 -- 254 7 4.5 156 62 -- 321
Total 87 59.6 146 * 117 -- 180 45.0 33.0 136 99 -- 182 42 27.1 155 * 112 -- 209
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 1
Leukemia Incidence
Marlborough, MA
1982-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 0 1.5 NC NC -- NC 0 0.7 NC NC -- NC 0 0.7 NC NC -- NC
3212 2 2.2 NC NC -- NC 0 1.2 NC NC -- NC 2 1.0 NC NC -- NC
3213 2 2.6 NC NC -- NC 1 1.4 NC NC -- NC 1 1.2 NC NC -- NC
3214 1 1.1 NC NC -- NC 0 0.6 NC NC -- NC 1 0.5 NC NC -- NC
3215 7 2.6 272 * 109 -- 561 5 1.3 372 * 120 -- 869 2 1.2 NC NC -- NC
3216 4 2.1 NC NC -- NC 2 1.2 NC NC -- NC 2 0.9 NC NC -- NC
Total 16 12.0 133 76 -- 216 8 6.4 125 54 -- 246 8 5.6 143 61 -- 281
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2
Leukemia Incidence
Marlborough, MA
1982-1986
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 4 1.9 NC NC -- NC 1 1.0 NC NC -- NC 3 0.9 NC NC -- NC
3212 2 2.7 NC NC -- NC 2 1.6 NC NC -- NC 0 1.1 NC NC -- NC
3213 8 2.9 272 * 117 -- 536 6 1.6 366 * 134 -- 796 2 1.3 NC NC -- NC
3214 2 1.3 NC NC -- NC 2 0.7 NC NC -- NC 0 0.6 NC NC -- NC
3215 6 2.9 206 75 -- 448 2 1.6 NC NC -- NC 4 1.3 NC NC -- NC
3216 4 2.6 NC NC -- NC 3 1.5 NC NC -- NC 1 1.1 NC NC -- NC
Total 26 14.4 180 * 118 -- 264 16 8.0 199 * 114 -- 323 10 6.4 157 75 -- 289
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3
Leukemia Incidence
Marlborough, MA
1987-1992
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 6 2.9 205 75 -- 446 4 1.6 NC NC -- NC 2 1.4 NC NC -- NC
3212 6 3.3 184 67 -- 401 5 1.8 272 88 -- 634 1 1.4 NC NC -- NC
3213 6 3.6 167 61 -- 363 3 2.0 NC NC -- NC 3 1.6 NC NC -- NC
3214 2 1.7 NC NC -- NC 0 0.9 NC NC -- NC 2 0.8 NC NC -- NC
3215 6 3.4 176 64 -- 383 1 1.8 NC NC -- NC 5 1.6 317 * 102 -- 739
3216 4 3.3 NC NC -- NC 2 1.9 NC NC -- NC 2 1.4 NC NC -- NC
Total 30 18.2 165 * 111 -- 236 15 10.1 149 83 -- 246 15 8.1 185 * 104 -- 305
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4
Leukemia Incidence
Marlborough, MA
1993-1998
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 2 2.9 NC NC -- NC 0 1.5 NC NC -- NC 2 1.4 NC NC -- NC
3212 4 2.8 NC NC -- NC 2 1.5 NC NC -- NC 2 1.3 NC NC -- NC
3213 2 3.0 NC NC -- NC 1 1.6 NC NC -- NC 1 1.4 NC NC -- NC
3214 0 1.5 NC NC -- NC 0 0.8 NC NC -- NC 0 0.7 NC NC -- NC
3215 4 2.8 NC NC -- NC 2 1.5 NC NC -- NC 2 1.4 NC NC -- NC
3216 3 2.8 NC NC -- NC 1 1.6 NC NC -- NC 2 1.2 NC NC -- NC
Total 15 15.9 94 53 -- 155 6 8.5 70 26 -- 153 9 7.4 122 55 -- 231
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI95% CI 95% CI
TABLE 5
Leukemia Incidence
Marlborough, MA
1999-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 3 2.8 NC NC -- NC 2 1.9 NC NC -- NC 1 0.9 NC NC -- NC
3212 3 3.3 NC NC -- NC 2 2.4 NC NC -- NC 1 0.9 NC NC -- NC
3213 9 3.5 257 * 117 -- 488 5 2.6 192 62 -- 449 4 1.0 NC NC -- NC
3214 1 1.6 NC NC -- NC 1 1.2 NC NC -- NC 0 0.5 NC NC -- NC
3215 6 3.3 182 66 -- 396 3 2.3 NC NC -- NC 3 1.0 NC NC -- NC
3216 6 3.2 188 68 -- 408 5 2.5 200 64 -- 467 1 0.7 NC NC -- NC
Total 28 18.0 156 * 103 -- 225 18 13.0 138 82 -- 219 10 4.9 204 98 -- 375
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6
Liver Cancer Incidence
Marlborough, MA
1982-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
3212 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
3213 4 0.5 NC NC -- NC 2 0.4 NC NC -- NC 2 0.2 NC NC -- NC
3214 1 0.2 NC NC -- NC 1 0.1 NC NC -- NC 0 0.1 NC NC -- NC
3215 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
3216 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
Total 5 2.5 202 65 -- 473 3 1.6 NC NC -- NC 2 0.8 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7
Liver Cancer Incidence
Marlborough, MA
1982-1986
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
3212 0 0.7 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
3213 3 0.8 NC NC -- NC 2 0.5 NC NC -- NC 1 0.2 NC NC -- NC
3214 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
3215 2 0.7 NC NC -- NC 0 0.5 NC NC -- NC 2 0.2 NC NC -- NC
3216 1 0.7 NC NC -- NC 1 0.5 NC NC -- NC 0 0.2 NC NC -- NC
Total 6 3.7 162 59 -- 352 3 2.6 NC NC -- NC 3 1.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8
Liver Cancer Incidence
Marlborough, MA
1987-1992
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 1 0.9 NC NC -- NC 1 0.6 NC NC -- NC 0 0.3 NC NC -- NC
3212 2 1.0 NC NC -- NC 1 0.8 NC NC -- NC 1 0.3 NC NC -- NC
3213 1 1.1 NC NC -- NC 0 0.8 NC NC -- NC 1 0.3 NC NC -- NC
3214 0 0.5 NC NC -- NC 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC
3215 2 1.0 NC NC -- NC 2 0.7 NC NC -- NC 0 0.3 NC NC -- NC
3216 4 1.0 NC NC -- NC 3 0.8 NC NC -- NC 1 0.2 NC NC -- NC
Total 10 5.6 179 86 -- 329 7 4.1 170 68 -- 351 3 1.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9
Liver Cancer Incidence
Marlborough, MA
1993-1998
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 2 1.1 NC NC -- NC 1 0.8 NC NC -- NC 1 0.3 NC NC -- NC
3212 1 1.1 NC NC -- NC 1 0.8 NC NC -- NC 0 0.3 NC NC -- NC
3213 1 1.1 NC NC -- NC 1 0.9 NC NC -- NC 0 0.3 NC NC -- NC
3214 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
3215 2 1.1 NC NC -- NC 1 0.8 NC NC -- NC 1 0.3 NC NC -- NC
3216 1 1.1 NC NC -- NC 1 0.9 NC NC -- NC 0 0.2 NC NC -- NC
Total 7 6.2 112 45 -- 232 5 4.7 106 34 -- 247 2 1.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI95% CI 95% CI
TABLE 10
Liver Cancer Incidence
Marlborough, MA
1999-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 61 59.8 102 78 -- 131 37 31.8 116 82 -- 160 24 28.0 86 55 -- 128
3212 83 75.4 110 88 -- 136 46 43.4 106 78 -- 141 37 31.7 117 82 -- 161
3213 94 79.1 119 96 -- 145 65 45.0 144 * 111 -- 184 29 34.1 85 57 -- 122
3214 41 36.3 113 81 -- 153 23 21.5 107 68 -- 161 18 14.8 122 72 -- 192
3215 85 75.0 113 91 -- 140 52 42.7 122 91 -- 160 33 32.3 102 70 -- 143
3216 73 69.4 105 82 -- 132 40 40.7 98 70 -- 134 33 28.6 115 79 -- 162
Total 437 394.8 111 * 101 -- 122 263 225.2 117 * 103 -- 132 174 169.7 103 88 -- 119
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11
Lung Cancer Incidence
Marlborough, MA
1982-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 13 9.3 139 74 -- 238 7 5.4 130 52 -- 268 6 3.9 152 56 -- 331
3212 15 15.1 99 55 -- 164 9 9.7 92 42 -- 175 6 5.4 112 41 -- 243
3213 19 17.1 111 67 -- 174 16 10.8 148 85 -- 241 3 6.3 NC NC -- NC
3214 8 6.6 121 52 -- 239 5 4.4 115 37 -- 268 3 2.2 NC NC -- NC
3215 20 16.3 123 75 -- 189 12 10.3 117 60 -- 204 8 6.0 133 57 -- 261
3216 9 13.1 69 31 -- 131 8 8.4 95 41 -- 188 1 4.7 NC NC -- NC
Total 84 77.6 108 86 -- 134 57 49.0 116 88 -- 151 27 28.6 94 62 -- 137
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12
Lung Cancer Incidence
Marlborough, MA
1982-1986
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 19 14.1 134 81 -- 210 11 7.6 144 72 -- 258 8 6.5 123 53 -- 243
3212 33 20.4 162 * 111 -- 227 20 12.3 162 99 -- 251 13 8.0 162 86 -- 276
3213 36 21.2 170 * 119 -- 235 23 12.5 184 * 117 -- 276 13 8.7 150 80 -- 256
3214 7 9.1 77 31 -- 158 3 5.6 NC NC -- NC 4 3.5 NC NC -- NC
3215 22 20.6 107 67 -- 162 13 12.0 108 57 -- 185 9 8.5 106 48 -- 201
3216 23 18.7 123 78 -- 184 12 11.4 105 54 -- 184 11 7.3 150 75 -- 268
Total 140 104.1 134 * 113 -- 159 82 61.6 133 * 106 -- 165 58 42.6 136 103 -- 176
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 13
Lung Cancer Incidence
Marlborough, MA
1987-1992
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 17 19.4 88 51 -- 141 9 10.2 88 40 -- 168 8 9.2 87 38 -- 172
3212 21 22.7 93 57 -- 142 11 12.6 87 43 -- 156 10 10.0 100 48 -- 183
3213 17 23.6 72 42 -- 115 14 12.9 108 59 -- 182 3 10.7 NC NC -- NC
3214 12 11.3 106 55 -- 185 8 6.5 122 53 -- 241 4 4.8 NC NC -- NC
3215 26 22.3 117 76 -- 171 16 12.2 132 75 -- 214 10 10.1 99 47 -- 182
3216 26 21.3 122 80 -- 179 10 12.2 82 39 -- 151 16 9.1 176 * 101 -- 286
Total 119 120.3 99 82 -- 118 68 66.5 102 79 -- 130 51 53.8 95 71 -- 125
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 14
Lung Cancer Incidence
Marlborough, MA
1993-1998
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 12 17.0 71 36 -- 123 10 8.6 117 56 -- 215 2 8.4 NC NC -- NC
3212 14 17.2 82 45 -- 137 6 8.8 68 25 -- 148 8 8.3 96 41 -- 189
3213 22 17.2 128 80 -- 193 12 8.8 136 70 -- 237 10 8.4 119 57 -- 219
3214 14 9.3 150 82 -- 252 7 5.0 141 57 -- 291 7 4.3 161 65 -- 332
3215 17 15.8 107 62 -- 172 11 8.2 135 67 -- 241 6 7.7 78 29 -- 170
3216 15 16.3 92 52 -- 152 10 8.7 115 55 -- 211 5 7.5 66 21 -- 155
Total 94 92.8 101 82 -- 124 56 48.1 117 88 -- 151 38 44.7 85 60 -- 117
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI95% CI 95% CI
TABLE 15
Lung Cancer Incidence
Marlborough, MA
1999-2002
  
Census Tract
Obs Exp SIR Obs Exp SIR Obs Exp SIR
3211 1 1.0 NC NC -- NC 0 0.5 NC NC -- NC 1 0.4 NC NC -- NC
3212 1 1.1 NC NC -- NC 1 0.6 NC NC -- NC 0 0.5 NC NC -- NC
3213 1 1.3 NC NC -- NC 1 0.7 NC NC -- NC 0 0.5 NC NC -- NC
3214 2 0.6 NC NC -- NC 1 0.4 NC NC -- NC 1 0.3 NC NC -- NC
3215 2 1.2 NC NC -- NC 2 0.6 NC NC -- NC 0 0.5 NC NC -- NC
3216 4 1.4 NC NC -- NC 4 0.8 NC NC -- NC 0 0.7 NC NC -- NC
Total 11 6.6 167 83 -- 298 9 3.7 243 * 111 -- 462 2 2.9 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Total Males Females
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and 
Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 16
Childhood Leukemia Incidence
Marlborough, MA
1982-2002
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
1983-20021 C85-0007
RTE. 495 SOUTH OFF 
RTE. 20 TRUCK ACCIDENT #2 FUEL OIL (UNK GAL) 1/9/1985 VEH. FUEL TANK
Mapped C85-0083
MASS CONTAINER, 
CEDAR HILL RD EARL DREW AND SONS #6 FUEL OIL (UNK GAL) 5/6/1985 U.S.T.
Not Mapped C85-0157 GAYE ST
OIL/ANTIFREEZE SPILL AT 
RESID.
OTHER MATERIAL, MOTOR OIL 
AND ANTIFREEZE (UNK GAL) 7/30/1985
OTHER SOURCE, 
AUTOMOBILE
Mapped C85-0197 75 LAKE SHORE DR
OIL RELEASE AT 
RESIDENCE #2 FUEL OIL (UNK GAL) 9/26/1985 ABOVE-GRND TANK
Not Mapped C85-0268
RTE. 20, BORROWS 
SHOPPING PLZA
OIL ODORS IN CATCH 
BASIN #2 FUEL OIL (UNK) 12/13/1985
Not Mapped C85-0269
INDIAN HILL 
SHOPPING CENTER
SIGNAL DELIVERY 
SERVICES DIESEL FUEL (UNK GAL) 12/16/1985 VEH. FUEL TANK
Mapped C86-0050 169 BROAD ST LEACROIX PROPERTY #2 FUEL OIL 2/28/1986
OTHER SOURCE, 
FEED LNE/BOILER
Mapped C86-0058 THRESHER DR
MARLBORO MIDDLE 
SCHOOL WASTE OIL (10-50 GAL) 3/11/1986 U.S.T.
Not Mapped C86-0066 RTE 20/BUILDING #4
METRO CORP. 
CENTER/RAYTHEON
OTHER MATERIAL, FLOOR 
ADHESIVE 3/13/1986
OTHER SOURCE, 
DUMPSTER
Mapped 2-0000087 270 WEST MAIN ST PROPERTY
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/24/1986 COMMERCIAL
Mapped C86-0159 270 W. MAIN ST HUNT'S MOBIL GASOLINE (10-50 GAL) 6/8/1986 U.S.T.
Not Mapped C86-0160 GARMENTER RD
SLICK IN WATER ON MDC 
LAND 6/8/1986
Mapped C86-0231 PAMENTER RD
ABONDONED DRUM 
SUDBURY RESEVOIR
OTHER MATERIAL, PHOSPHORIC 
ACID (51-100 GAL) 8/1/1986 DRUM
Mapped C86-0295 121 NORTHBORO RD
BRAENOOR NURSING 
HOME #2 FUEL OIL (UNK GAL) 9/17/1986 U.S.T.
Mapped C86-0287
175 MAPLE ST, 
DESIGN PACK MARANE OIL #4 FUEL OIL (101-250 GAL) 9/18/1986 U.S.T.
Mapped C86-0300
UNION ST, MARL JR. 
HIGH SCHOOL
MARLBORO SCHOOL 
DEPT #2 FUEL OIL (1001-5000 GAL) 9/24/1986 U.S.T.
Mapped C86-0336
HILLSIDE SCHOOL, 
ROBIN HILL RD CK SMITH #2 FUEL OIL (UNK GAL) 10/20/1986 PIPE/HOSE/LINE
Mapped C86-0366
290 TO 495 NORTH ON 
RAMP
TRANSPORT PLANNING & 
SERVICE
OTHER MATERIAL, HYCAR" 
LATEX" (LESS THAN 1 GAL) 11/10/1986 TANKER TRUCK
Mapped C87-0010 7 CHURCH ST
ABOVE GND TANK 
RUPTURE #2 FUEL OIL 1/13/1987 ABOVE-GRND TANK
Mapped 2-0000085 120 BARTLETT ST BUTCHER POLISH CO
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 1/15/1987 INDUSTRIAL UNKNOWN
Mapped 2-0000093 247 MAPLE ST
OLD COLONY GAS 
STATION
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 1/15/1987 GASSTATION UST
Mapped 2-0000088 401 ELM ST HONEYWELL
UNKNOWN CHEMICAL OF TYPE - 
OIL 1/15/1987
COMMERCIAL, 
MANUFACT DRUMS, DRYWELL
Mapped C87-0181 215 MAPLE ST
ABANDONED GASOLINE 
TANK GASOLINE (UN ) 1/22/1987 U.S.T.
Not Mapped C87-0044 63 MILL ST TANKER TRUCK LEAK DIESEL FUEL (101-250 GAL) 2/5/1987 TANKER TRUCK
Table 17 - Environmental Release and Spill Sites in Marlborough, MA 1
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Mapped C87-0081 ROBIN HILL RD
PATTEN HOUSE/HILLSIDE 
SCHOOL #2 FUEL OIL (51-100 GAL) 3/7/1987 ABOVE-GRND TANK
Mapped C87-0238 420 MAPLE ST CAR IN POND
OTHER MATERIAL, GASOLINE & 
CRANKCASE OIL (UNK) 6/5/1987 VEH. FUEL TANK
Mapped C87-0260 RTE. 290 @ 495 TRUCK ACCIDENT DIESEL FUEL (101-250 GAL) 6/19/1987 VEH. FUEL TANK
Mapped C87-0326 100 NICKERSON RD ETHYLENE GLYCOL 6/20/1987
Mapped 2-0000092 260 WEST MAIN ST
MOBIL GAS STATION 01 
POA
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 7/15/1987 COMMERCIAL PIPE
Mapped C87-0112 235 BOSTON POST RD MARLBORO LUBRICATING OIL (501-1000 GAL) 7/29/1987 PIPE/HOSE/LINE
Mapped C87-0312 235 BOSTON POST RD OIL PIPE RUPTURE LUBRICATING OIL (UNK) 7/29/1987 PIPE/HOSE/LINE
Mapped C87-0338 167 LAKESIDE SODIUM HYDROXIDE 8/19/1987 DRUM
Mapped C87-0355
MAPLE ST AND JOHN 
ST RTE #85 MARLBORO GASOLINE (1-10 GAL) 8/28/1987 VEH. FUEL TANK
Mapped C87-0427 554 BOSTON POST RD CUMBERLAND FARMS PERCHLOROETHYLENE (UNK) 10/22/1987 PIPE/HOSE/LINE
Mapped C87-0467
40 CRANE MEADOW 
RD WASTE OIL 11/19/1987 ABOVE-GRND TANK
Mapped C87-0490
40 CRANE MEADOW 
RD STOP & SHOP WASTE OIL 11/19/1987 ABOVE-GRND TANK
Mapped C87-0489
1001 BOSTON POST 
RD RAYTHEON #2 FUEL OIL (251-500 GAL) 12/10/1987 U.S.T.
Not Mapped C87-0499 BOSTON POST RD TANKER TRUCK SPILL DIESEL FUEL (101-250 GAL) 12/15/1987 VEH. FUEL TANK
Not Mapped C88-0006 BEACH ST GASOLINE (1-10 GAL) 1/11/1988
OTHER SOURCE, 
PORTABLE TANK
Mapped C88-0008
85 HAYES MEMORIAL 
DR MINERAL SPIRITS (1-10 GAL) 1/12/1988
OTHER SOURCE, 
TRUCK
Not Mapped C88-0027 1034 E. MAIN ST #2 FUEL OIL (1-10 GAL) 1/17/1988 ABOVE-GRND TANK
Not Mapped C88-0695 83 MILL ST
MISCELLANEOUS OIL (101-250 
GAL) 2/5/1988
Not Mapped C88-0122 HARUND ST WASTE OIL 3/15/1988 ABOVE-GRND TANK
Not Mapped C88-0107 HARVARD ST TONIFER CORP. WASTE OIL (10-50 GAL) 3/15/1988 PIPE/HOSE/LINE
Not Mapped C88-0180 BRIGHAM ST
N.E. TELEPHONE 
LEARNING SCHOOL GASOLINE 4/12/1988
OTHER SOURCE, 
RESIDUAL GAS
Not Mapped C88-0187 RT. 20 WEST DIESEL FUEL (10-50 GAL) 4/19/1988 VEH. FUEL TANK
Not Mapped C88-0183 MAIN ST FIRE DEPT DIESEL FUEL (10-50 GAL) 4/21/1988 VEH. FUEL TANK
Mapped C88-0270 413 LAKESIDE AVE SHELL STATION GASOLINE 6/20/1988 U.S.T.
Not Mapped C88-0689 BARTLET ST SHIPLEY CHEMICAL UNKNOWN 7/15/1988
OTHER SOURCE, 
BOTTLES OF UNK
Mapped C88-0394
LAKE WILLIAMS 
RESERVOIR UNKNOWN 8/4/1988
Mapped C88-0417 152 DARTMOUTH ST GASOLINE (10-50 GAL) 8/15/1988 VEH. FUEL TANK
Mapped C88-0423
MILL ST AND SOUTH 
ST HYDRAULIC FLUID (10-50 GAL) 8/18/1988 PIPE/HOSE/LINE
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Mapped C88-0520 UNION ST MIDDLE SCHOOL #6 FUEL OIL 9/26/1988 U.S.T.
Mapped C88-0523 386 MAPLE ST GASOLINE (10-50 GAL) 10/2/1988 VEH. FUEL TANK
Mapped 2-0000292 114 EAST MAIN ST MARLBORO EXXON PETROLEUM BASED OIL 10/15/1988 GASSTATION UNKNOWN
Mapped 2-0000446 146 MAPLE ST GULF STATION
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/15/1988 GASSTATION UST
Mapped 2-0000317 230 MAPLE ST
BEACON 
COMMUNICATIONS CORP
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/15/1988
Mapped 2-0000403 247A MAPLE ST KENNEDYS PUB
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/15/1988
Not Mapped C88-0674 RTE 20 LAKESIDE AVE NON-PETROLEUM OIL 10/21/1988 DRUM
Not Mapped C88-0528 RTE 20 WEST GASOLINE 11/6/1988 U.S.T.
Mapped 2-0000086 134 WEST MAIN ST ACME GLASS
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 1/15/1989
Mapped 2-0000332 311 MAPLE ST SUPERIOR AUTOBODY
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 1/15/1989
Mapped 2-0000464 656 BOSTON POST RD STARRETT PAVING CO
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 1/15/1989
Mapped C89-0048 123 FELTON ST
COEHLER 
MANUFACTURING CO.
OTHER MATERIAL, LEAD 
CARBONATE (UNK) 1/17/1989
OTHER SOURCE, 
TANK
Not Mapped C89-0099
SOUTH ST PAST EMIT 
OFF WST #2 FUEL OIL (101-250 GAL) 2/24/1989 PIPE/HOSE/LINE
Mapped C89-0116 255 EAST MAIN ST SOLVENT 3/6/1989 DRUM
Mapped 2-0000482 187 MILLHAM RD
187 MILLHAM RD 
PROPERTY
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/15/1989
Mapped 2-0000559 413 LAKESIDE AVE SHELL OIL COMPANY
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/15/1989 GASSTATION UST
Mapped 2-0000225 843 BOSTON POST RD
GIROUX BROS 
TRANSPORTATION
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/15/1989
Not Mapped 2-0000585 AMES GLEN ST METAL GOODS PARCEL
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/15/1989
Mapped C89-0214 112 FOREST ST MINERAL SPIRITS 4/26/1989
OTHER SOURCE, 
FROM CONTAINER
Mapped C89-0238 342 BOSTON POST RD GASOLINE (UNK) 5/3/1989 U.S.T.
Not Mapped C89-0284 SHERMAN ST RESERVOIR GASOLINE (UNK ) 5/11/1989 VEH. FUEL TANK
Mapped C89-0291 100 PHELP RD OTHER MATERIAL, FERTILIZER 5/18/1989 PIPE/HOSE/LINE
Mapped C89-0293 40 CEDAR HILL RD SODIUM HYDROXIDE 5/22/1989
OTHER SOURCE, 
UNKNOWN
Mapped 2-0000516 103 EAST MAIN ST PROPERTY PETROLEUM BASED OIL 6/5/1989 RESIDNTIAL AST
Not Mapped C89-0330 RT 20 UNKNOWN (UNK) 6/8/1989
OTHER SOURCE, 
DUMPSTER
Mapped C89-0361
543 BROAD & LINCOLN 
ST GASOLINE (UNK) 6/20/1989 U.S.T.
Not Mapped C89-0366 MAIN ST GASOLINE (UNK) 6/21/1989 PIPE/HOSE/LINE
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Mapped C89-0386 265 EUELINA DR
OTHER MATERIAL, PESTICIDES (1-
10 GAL) 6/29/1989 TANKER TRUCK
Mapped 2-0000655 123 FELTON ST
KOEHLER 
MANUFACTURING
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 7/15/1989 MANUFACT
Mapped 2-0000634 215 MAPLE ST
SPACE AGE 
ELECTRONICS
CYANIDE, PETROLEUM BASED 
OIL, UNKNOWN CHEMICAL OF 
TYPE - HAZARDOUS MATERIAL, 
UNKNOWN CHEMICAL OF TYPE - 
OIL, UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 7/15/1989
COGASPLANT, 
FORMER, 
INDUSTRIAL LAGOON, UNKNOWN
Not Mapped C89-0475 AMES ST
TRUCKLEASE CO. TRUCK 
LEAK DIESEL FUEL (10-50) 8/11/1989 VEH. FUEL TANK
Mapped C89-0474 PARMENTER RD MDC RESERVIOR GASOLINE 8/11/1989 VEH. FUEL TANK
Mapped C89-0512 BOSTON POST RD GOTHAM, INC.
OTHER MATERIAL, TITANIUM 
DIOXIDE (1-10 UNK) 8/30/1989
OTHER SOURCE, 5 
GAL CONTAINER
Mapped C89-0534 202 LAKESHORE AVE
DUMPSTER LIQUID 
RELEASE
ACID (MISCELLANEOUS) (1-10 
UNK) 9/13/1989
OTHER SOURCE, 
DUMPSTER
Not Mapped C89-0567 DOUCETTE DR SOIL DISPOSAL-KANE
OTHER MATERIAL, PETROLEUM 
CONTAMINATED (10-50 UNK) 9/20/1989
OTHER SOURCE, 
DUMP TRUCK
Mapped C89-0602 50A BRIGHAM ST SAFETY KLEEN CORP.
PERCHLOROETHYLENE (10-50 
GAL) 10/11/1989 DRUM
Not Mapped C89-0603 LOWER MILLHAM RD
MARLBORO FISH & GAME 
PROPERTY
OTHER MATERIAL, VEGETABLE 
OIL (UNK) 10/12/1989
OTHER SOURCE, 
UNKNOWN
Not Mapped 2-0000661
639 883 BOSTON POST 
RD INDIAN HILL PARK BTEX 10/15/1989
OPENSPACE, 
WETLANDS
DRUMS, LAGOON, 
PIPE
Not Mapped C89-0612 MAIN ST, RTE 20
MARLBOROUGH FIRE 
STATION
OTHER MATERIAL, GASOLINE 
CONTAM. DEBRIS (< 1 DRUM) 10/19/1989 DRUM
Mapped C89-0621 54 MECHANIC ST TANK OVERFILL #2 FUEL OIL (51-100 GAL) 10/25/1989 PIPE/HOSE/LINE
Mapped 2-0000647 86 PLEASANT ST
OLD WEST MEETING 
HOUSE
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/31/1989 COMMERCIAL UST
Mapped C89-0659 MEAL & VALLY ST MARLBOROUGH DPW GASOLINE 11/13/1989 U.S.T.
Mapped C89-0679 VALLEY ST MARLBOROUGH DPW HYDRAULIC FLUID 11/20/1989
OTHER SOURCE, 
FRONTEND LOADER
Mapped 2-0000687 445 LAKESIDE AVE MARANE OIL PETROLEUM BASED OIL 11/22/1989 GASSTATION UST
Mapped C89-0759 300 CEDAR HILL RD MASS. CONTAINER CORP. #2 FUEL OIL (UNK) 12/18/1989 U.S.T.
Mapped C89-0746 300 CEDAR HILL ST
MASSACHUSETTS 
CONTAINER CORP. DIESEL FUEL (UNK) 12/18/1989 U.S.T.
Not Mapped C90-0077 RTE 85 GASOLINE (10-50 CUBIC YDS) 2/15/1990
OTHER SOURCE, 
MYSTERY
Mapped C90-0195 50A BRIGHAM ST SAFTY KLEEN
OTHER MATERIAL, PETROLEUM 
NAPTHA 4/5/1990 PIPE/HOSE/LINE
Mapped C90-0256 RTE. 20 & FELTERS ST SHELL OIL SPILL GASOLINE (LESS THAN 1 GAL) 4/26/1990 VEH. FUEL TANK
Mapped C90-0281 529 BOSTON POST RD MOBIL OIL CO. GASOLINE 5/9/1990
OTHER SOURCE, ST.II 
VAP. REC.
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Not Mapped C90-0310 SAFETY KLEEN SOLVENTS 5/17/1990 DRUM
Mapped C90-0329 FARM RD AIRPORT CRASH AVIATION GAS (1-10 GAL) 5/27/1990 VEH. FUEL TANK
Mapped C90-0347 91 MAIN ST HYDRAULIC FLUID HYDRAULIC FLUID 6/5/1990 PIPE/HOSE/LINE
Not Mapped C90-0364
I-495 & MASS PIKE (EX. 
11A) BUILDERS TRANSPORT DIESEL FUEL (10-50 GAL) 6/11/1990 VEH. FUEL TANK
Mapped 2-0000763 279 MAPLE ST
MARLCO FACILITY 98 MRL 
FORMER GASOLINE 6/26/1990
COMMERCIAL, 
GASSTATION UST
Mapped 2-0000774 329-331 LINCOLN ST FOSSILE CONSTRUCTION PETROLEUM BASED OIL 7/3/1990
FORMER, 
GASSTATION UST
Mapped C90-0418 364 MAPLE ST
GARAGE-WASTE OIL 
RELEASE
OTHER MATERIAL, GASOLINE & 
WASTE OIL (UNK) 7/9/1990 ABOVE-GRND TANK
Mapped C90-0568 167 NORTHBORO RD BOROUGH'S TIRE CO. WASTE OIL (UNK) 7/13/1990
OTHER SOURCE, 
CATCH BASIN
Mapped 2-0000751
111 HAYES MEMORIAL 
DR NEC TECHNOLOGIES INC
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 8/8/1990
Mapped C90-0590
RTE. 290 EAST 
RAMP/TO RTE. 495 CARTER'S TRUCKING DIESEL FUEL (10-50 GAL) 9/19/1990 VEH. FUEL TANK
Mapped C90-0701 237 CEDAR HILL RD ANCAN TRUCKING DIESEL FUEL 11/5/1990 VEH. FUEL TANK
Mapped C90-0721 67 CHESTNUT ST WASTE OIL DRUM SPILL WASTE OIL (10-50 GAL) 11/9/1990 DRUM
Mapped C90-0787
RTE 495 SOUTH/RTE 
290
TANKER ROLLOVER - 
W.M. HOLDMAN DIESEL FUEL (51-100 GAL) 12/11/1990 VEH. FUEL TANK
Mapped C91-0019 FELTON ST KOHLER MAUFACTURING
OTHER MATERIAL, MINERAL 
SPIRITS 1/12/1991 ABOVE-GRND TANK
Not Mapped C91-0032 FELTER ST
WASTE WATER 
TREATMENT PLANT
OTHER MATERIAL, MINERAL 
SPIRITS 1/17/1991
OTHER SOURCE, 
UNKNOWN
Mapped C91-0040 114 E. MAIN ST
NO SITUATION AT THIS 
TIME GASOLINE (UNK GAL) 1/24/1991
Mapped C91-0041 2 RESULTS WAY
DIGITAL EQUIPMENT 
CORP. #2 FUEL OIL 1/24/1991 U.S.T.
Mapped C91-0089
33 HAYES MEMORIAL 
DR ROTATION DYNAMICS #4 FUEL OIL 2/26/1991 TANKER TRUCK
Mapped C91-0138 410 LAKESIDE AVE EXXON IN EVERETTE GASOLINE (UNK GAL) 3/25/1991 U.S.T.
Mapped C91-0167 58 BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, MINERAL 
SPIRITS 4/9/1991 DRUM
Mapped 2-0000727 399 BERLIN RD HOUDE FARM FMR
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 4/15/1991 FARM UST
Mapped C91-0190 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, PETRO 
NAPTHA 4/23/1991
Mapped C91-0215 550 FARM RD DRUMS OF PAINT WASTE
OTHER MATERIAL, PAINT 
RELATED WASTE (UNK GAL) 5/2/1991 DRUM
Mapped C91-0242 111 LOCK DR DEC #2 FUEL OIL (UNK CUBIC YDS) 5/7/1991 U.S.T.
Not Mapped C91-0252 BEHIND BROOK ST
WASTE OIL DUMPED 
BEHIND DPW WASTE OIL (UNK GAL) 5/16/1991
Mapped C91-0441 495, 290
LEASWAY TRANSFER 
POOL DIESEL FUEL (UNK GAL) 7/10/1991 VEH. FUEL TANK
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
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Mapped C91-0383  496 LINCOLA ST
S.E. ESSEX 
OPPORTUNITY COUNCIL WASTE OIL 7/30/1991 VEH. FUEL TANK
Not Mapped C91-0414 MAIN ST
PAOLINI CONSTRUCTION 
CO. HYDRAULIC FLUID (1-10 GAL) 8/1/1991 PIPE/HOSE/LINE
Not Mapped C91-0423
RTE. 20 SHELL 
STATION HOLE IN M.V. GAS TANK GASOLINE (1-10 GAL) 8/15/1991 VEH. FUEL TANK
Mapped C91-0450 150 MAPLE ST SAFETY KLEEN
OTHER MATERIAL, MINERAL 
SPIRITS (UNK GAL) 8/29/1991 DRUM
Mapped C91-0475 43 MECHANIC ST DUMPING OF OIL
OTHER MATERIAL, OIL + 
ANTIFREEZE (UNK GAL) 9/10/1991 VEH. FUEL TANK
Mapped 2-0000856 771 BOSTON POST RD SALVAGE YARD FMR
UNKNOWN CHEMICAL OF TYPE - 
OIL 9/18/1991 JUNKYARD
Mapped C91-0512 FELTON ST KOELHER MFG.
OTHER MATERIAL, PETROLEUM 
NAPTHALINE (UNK) 9/24/1991
Not Mapped C91-0550 JOHANSON DR MASS ELECTRIC TRANSFORMER OIL (UNK GAL) 10/18/1991 TRANSFORMER
Mapped C91-0558 20 HIGH ST
CHANGED OIL AND 
DUMPED W. OIL LUBRICATING OIL (UNK GAL) 10/23/1991 VEH. FUEL TANK
Mapped C91-0581 58 BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, ANTIFREEZE 
(UNK GAL) 11/1/1991 PIPE/HOSE/LINE
Mapped C91-0615 50A BRIGHAM ST SAFETY KLEEN CORP. WASTE OIL (UNK GAL) 11/27/1991 TANKER TRUCK
Not Mapped C91-0661 PARMETER RD OVERTURNED CAMPER GASOLINE (UNK GAL) 12/28/1991 VEH. FUEL TANK
Mapped C92-0006 469 BOSTON POST RD
MOTOR OIL IN PARKING 
LOT MOTOR OIL (UNK GAL) 1/5/1992 VEH. FUEL TANK
Not Mapped C92-0016
RTE 20, PAST TIME 
RESTAURANT
RUPTURED VEHICLE 
FUEL TANK GASOLINE (11-50 GAL) 1/12/1992 VEH. FUEL TANK
Mapped 2-0000832 167 NORTHBORO RD BOROUGHS TIRE CO PETROLEUM BASED OIL 1/15/1992 GASSTATION UST
Mapped C92-0021 50A BRIGHAM ST SAFETY KLEEN CORP.
OTHER MATERIAL, WASTE 
PETROLEUM NAPHTHA (1-10 GAL) 1/16/1992 PIPE/HOSE/LINE
Mapped C92-0150 299 MAPLE ST FLYNN'S TEXACO GASOLINE (11-50 GAL) 4/10/1992 TANKER TRUCK
Mapped C92-0152
FOREST ST AT CEDAR 
HILL DRUMS
OTHER MATERIAL, POSSIBLE 
HYDRAULIC FLUID (UNK) 4/10/1992 DRUM
Mapped C92-0205 455 FOREST ST SHIPLEY CO.
OTHER MATERIAL, POTASSIUM 
PEROXYMONOSULFT (UNK) 5/5/1992 DRUM
Mapped C92-0216 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, PET NAPTHA, 
MINERAL SPRTS (UNK GAL) 5/8/1992 DRUM
Mapped C92-0214
I 495 SOUTH AND I 290 
WEST
DAY AND ROSS 
TRUCKING CO. DIESEL FUEL (101-250 GAL) 5/8/1992 VEH. FUEL TANK
Mapped C92-0277 431 LINCOLN ST SHELL SERVICE STATION GASOLINE (UNK CUBIC YDS) 6/4/1992
OTHER SOURCE, 
UNKNOWN
Mapped C92-0294
BARTLETT & HAYES 
MEMORIAL DR MASS ELECTRIC TRANSFORMER OIL (51-100 GAL) 6/11/1992 TRANSFORMER
Mapped C92-0287 50A BRIGHAM ST MINERAL SPIRITS MINERAL SPIRITS (1-10 GAL) 6/12/1992 TANKER TRUCK
Mapped C92-0312 RTE. 290 & RTE. 495
VALLERIE 
TRANSPORTATION DIESEL FUEL (11-50 GAL) 6/23/1992 VEH. FUEL TANK
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Mapped C92-0342 14 JOHN ST
NEW ENGLAND 
TELEPHONE GASOLINE (UNK) 7/10/1992 U.S.T.
Mapped 2-0000908 300 CEDAR HILL ST
MASSACHUSETTS 
CONTAINER CORP
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 8/26/1992 TANK FARM
Mapped C92-0431 529 BOSTON POST RD MOBIL SERVICE STATION GASOLINE (UNK) 8/27/1992 PIPE/HOSE/LINE
Mapped C92-0444 RTE. 495 S AT RTE. 20 MATUSZKO TRUCKING DIESEL FUEL (UNK GAL) 9/3/1992 VEH. FUEL TANK
Mapped 2-0000923 301 MAPLE ST
DIAMOND BULK OIL 
PLANT
OIL, UNKNOWN CHEMICAL OF 
TYPE - OIL 10/15/1992
COMMERCIAL, 
FORMER, TANK 
FARM AST, UST
Mapped C92-0521 14 MT. PLEASANT ST
RELEASE OF OIL AT 
RESIDENCE #2 FUEL OIL (UNK) 10/16/1992 U.S.T.
Not Mapped C92-0527 BRIGHAM ST
NEW ENGLAND 
TELEPHONE #2 FUEL OIL (UNK) 10/17/1992 U.S.T.
Mapped C92-0536 117 KINGS GRANT RD OIL SPILL AT RESIDENCE #2 FUEL OIL (1-10 GAL) 10/23/1992 ABOVE-GRND TANK
Mapped 2-0000961 299 MAPLE ST
TEXACO SERVICE 
STATION PETROLEUM BASED OIL 1/4/1993
COMMERCIAL, 
GASSTATION UNKNOWN
Mapped C93-0008 50A BRIGHAM ST SAFETY KLEEN SOLVENTS (UNK GAL) 1/7/1993
OTHER SOURCE, 
PUMP GASKET
Mapped C93-0058 455 FOREST ST SHIPLEY CO.
OTHER MATERIAL, FLUORINE 
GAS (UNK GAL) 2/8/1993
OTHER SOURCE, 
CYLINDER
Mapped C93-0083 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, WASTE 
MINERAL SPIRITS (UNK GAL) 2/22/1993 DRUM
Mapped C93-0090 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, MINERAL 
SPIRITS (1-10 GAL) 3/1/1993 TANKER TRUCK
Mapped C93-0119 5A BRIGHAM ST SAFETY CLEAN
OTHER MATERIAL, NAPTHA (1-10 
GAL) 3/18/1993 DRUM
Mapped C93-0248 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, PETROLEUM 
NAPTHA (1-10 GAL) 5/18/1993 DRUM
Not Mapped C93-0269 STREAM CAR IN STREAM GASOLINE (UNK GAL) 5/31/1993 VEH. FUEL TANK
Mapped 2-0001057 431 LINCOLN ST SHELL STATION PETROLEUM BASED OIL 7/13/1993 GASSTATION UST
Mapped 2-0000979
40 HAYES MEMORIAL 
DR HB FULLER COMPANY
UNKNOWN CHEMICAL OF TYPE - 
OIL 7/15/1993
INDUSTRIAL, 
MANUFACT
Mapped C93-0365 FARM RD
KANE ELEMENTARY 
SCHOOL DIESEL FUEL (UNK GAL) 7/29/1993 BELOW-GRND TANK
Mapped C93-0385 50A BRIGHAM ST SAFETY KLEEN
OTHER MATERIAL, PETROLEUM 
NAPTHA (1-10 GAL) 8/6/1993 DRUM
Mapped C93-0446 99 WEST MAIN ST LEAKING FILL LINE #2 FUEL OIL (UNK GAL) 8/30/1993 ABOVE-GRND TANK
Mapped C93-0462 53 RED SPRING RD #2 FUEL OIL (1-10 GAL) 9/16/1993 ABOVE-GRND TANK
Not Mapped 2-0001091 SOUTH ST MASS ELECTRIC
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 9/27/1993 SUBSTATION TRANSFORM
Not Mapped 2-0001086 BARTLETT ST MASS ELECTRIC
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 9/28/1993 SUBSTATION TRANSFORM
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Mapped 2-0010032 150 CEDAR HILL ST KENS FOODS
DIESEL FUEL, PETROLEUM 
BASED OIL, WASTE OIL 10/1/1993 COMMERCIAL UST
Mapped 2-0001087 223 MAPLE ST SUNOCO STATION
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/1/1993 GASSTATION UST
Not Mapped 2-0001078 DONALD LYNCH BLVD EL DAUPHINAIS
UNKNOWN CHEMICAL OF TYPE - 
OIL 10/1/1993 INDUSTRIAL UST
Mapped 2-0010143 299 MAPLE ST
TEXACO SERVICE 
STATION GASOLINE 10/14/1993 COMMERCIAL UNKNOWN
Mapped 2-0010083 215 MAPLE ST
PROPOSED FIRE 
STATION
COAL TAR PITCH (150 GAL), 
WASTE OIL (36 GAL) 11/15/1993 MUNICIPAL PIPE
Mapped 2-0010101 82 FLORENCE ST POLE 8
MINERAL OIL (12 GAL), MINERAL 
OIL (40 GAL) 11/28/1993 ROADWAY TRANSFORM
Mapped 2-0010125 197 NORTHBORO RD
INT RTE 20 NEXT TO 
MCDONALDS GASOLINE 12/15/1993
COMMERCIAL, 
ROADWAY UNKNOWN
Mapped 2-0010167 53 RED SPRING RD RESIDENTIAL
PETROLEUM BASED OIL, 
PETROLEUM BASED OIL 1/24/1994 RESIDNTIAL AST
Mapped 2-0010177 129 WOODLAND DR DRIVEWAY
FUEL OIL #2 (10 GAL), FUEL OIL #2 
(10 GAL) 1/28/1994 RESIDNTIAL TANKER
Mapped 2-0010185 50A BRIGHAM ST SAFETY KLEEN FACILITY
AROMATIC SOLVENT (33.5 LBS), 
AROMATIC SOLVENT (5 GAL) 2/7/1994 COMMERCIAL DRUMS
Mapped 2-0010249 197 NORTHBORO RD
RK PLAZA NEXT TO 
MCDONALDS
2-BUTANONE, 2-BUTANONE (2500 
GAL) 3/15/1994 COMMERCIAL UTILITY, VAULT
Mapped 2-0010300 455 FOREST ST SHIPLEY CO
2-PROPANOL, 1-METHOXY- (800 
LBS), 2-PROPANOL, 1-METHOXY- 
(800 LBS) 5/6/1994 COMMERCIAL DRUMS
Mapped 2-0010336 25 BROAD ST ST MARYS CHURCH
FUEL OIL #2 (10 GAL), FUEL OIL #2 
(50 PPMV) 6/16/1994 CHURCH UST
Mapped 2-0010525
40 CRANE MEADOW 
RD COR CEDAR HILL RD AMMONIA, AMMONIA (50 LBS) 10/26/1994
COMMERCIAL, 
INDUSTRIAL PIPE
Mapped 2-0010629 342 BOSTON POST RD SHELL SERVICE STA
BENZENE, DIMETHYL (7800 PPB), 
BENZENE, METHYL- (12000 PPB) 1/10/1995 COMMERCIAL FUEL TANK
Mapped 2-0010699 146 MAPLE ST
BAKERLY CITGO-KING 
BRAKES DIESEL FUEL, GASOLINE 3/11/1995
COMMERCIAL, 
INDUSTRIAL, 
ROADWA PIPE, UST
Mapped 2-0010724 289 ELM ST MACNEILL ENG LUBRICATING OIL (25 GAL) 4/11/1995 INDUSTRIAL AST
Mapped 2-0010742 21 PROSPECT ST
IMMACULATE 
CONCEPTION CHURCH
FUEL OIL #2 (100 PPMV), 
PETROLEUM BASED OIL (50 
PPMV) 4/21/1995 UST
Mapped 2-0010787 202 RESERVOIR RD UTIL POLE 16 MINERAL OIL (25 GAL) 5/21/1995
RIGHTOFWAY, 
ROADWAY TRANSFORM
Mapped 2-0010795 100 CEDAR HILL ST SUBURBAN PROPANE DIESEL FUEL (220 PPMV) 5/24/1995 COMMERCIAL UST
Mapped 2-0010881 300 CEDAR HILL ST MA CONTAINER CORP DIESEL FUEL (3800 PPM) 8/9/1995 INDUSTRIAL UNKNOWN
Mapped 2-0010892 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF TYPE - 
OIL (3 GAL) 8/24/1995 COMMERCIAL DRUMS
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Mapped 2-0010911 50A BRIGHAM ST SAFETY KLEEN FACILITY
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (10 GAL) 9/13/1995 COMMERCIAL DRUMS
Mapped 2-0010914 50A BRIGHAM ST SAFETY KLEEN CORP
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (10 GAL) 9/14/1995 COMMERCIAL DRUMS
Mapped 2-0011001 342 BOSTON POST RD SHELL SERVICE STA
TOTAL PETROLEUM 
HYDROCARBONS (TPH) (930 
MG/KG) 11/14/1995 COMMERCIAL MIX TRAP
Mapped 2-0011038 50A BRIGHAM ST SAFETY KLEEN FACILITY
UNKNOWN CHEMICAL OF TYPE - 
OIL (7 GAL) 12/14/1995 COMMERCIAL DRUMS
Mapped 2-0011048 300 CEDAR HILL ST MASS CONTAINER CORP FUEL OIL #4 (50 GAL) 12/26/1995 COMMERCIAL UST
Mapped 2-0011132 FLORENCE ST FLORENCE ST SUBSTA
UNKNOWN CHEMICAL OF TYPE - 
OIL (57 PPM) 2/5/1996
COMMERCIAL, 
ROADWAY TRANSFORM
Mapped 2-0011108 123 FELTON ST
KOEHLER 
MANUFACTURING SULFURIC ACID (1200 GAL) 2/15/1996 INDUSTRIAL TANKER
Mapped 2-0011118 CEDAR HILL ST DANGELO DRIVE DIESEL FUEL (80 GAL) 2/21/1996
COMMERCIAL, 
ROADWAY TANKER
Mapped 2-0011164 740 BOSTON POST RD NISSAN DEALERSHIP GASOLINE (250 PPMV) 3/19/1996 COMMERCIAL UST
Not Mapped 2-0011190 SOLOMON POND RD
ROADWAY RELEASE - 
ACROSS FROM SUPER 8 DIESEL FUEL (100 GAL) 4/8/1996 ROADWAY VEHICLE
Mapped 2-0011222 50A BRIGHAM ST SAFETY KLEEN FACILITY WASTE OIL 5/9/1996 COMMERCIAL RRCAR
Not Mapped 2-0011240 RTE 290 E
1 MI E OF SOLOMON 
POND DIESEL FUEL (20 GAL) 5/22/1996 ROADWAY PIPE
Mapped 2-0011409 457 BOLTON ST NAVIN SKATING RINK
METHANE, TRICHLOROFLUORO- 
(3500 LBS) 9/21/1996 STATE REFRIGATN, SYSTEM
Not Mapped 2-0011414 DANGELO DR
BTWN CEDAR HILL ST 
AND FOREST ST ASBESTOS 9/26/1996
OPENSPACE, 
ROADSIDE
2 BAGS OF, 
ASBESTOS
Mapped 2-0011445 146 MAPLE ST
BAKERLY CITGO-KING 
BRAKES GASOLINE (2.5 INCH) 10/18/1996 COMMERCIAL PIPE, UST
Mapped 2-0011486 413 LAKESIDE AVE SHELL SERVICE STA
GASOLINE (.05 GAL/HR), 
GASOLINE (323 PPMV) 11/18/1996 COMMERCIAL PIPE
Mapped 2-0011575 50A BRIGHAM ST SAFETY KLEEN SODIUM HYDROXIDE (95 GAL) 1/21/1997 COMMERCIAL 3 55 GAL, DRUMS
Mapped 2-0011648 RTE 290 AT RTE 495 DIESEL FUEL (100 GAL) 3/20/1997 ROADWAY VEHICLE
Mapped 2-0011728 50A BRIGHAM ST SAFETY KLEEN
AROMATIC SOLVENT (200 GAL), 
AROMATIC SOLVENT (392 GAL) 5/20/1997 COMMERCIAL AST
Mapped 2-0011998 84 CHESTNUT ST FRYE TANNER
OIL, UNKNOWN CHEMICAL OF 
TYPE - HAZARDOUS MATERIAL 7/28/1997 INDUSTRIAL
DRUMS, FORMER, 
OPERATIONS, TAN
Mapped 2-0011882 417 MAPLE ST
A&P TRANSPORTATION 
FACILITY DIESEL FUEL (160 PPMV) 9/18/1997 COMMERCIAL UST
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Mapped 2-0011887 247 MAPLE ST COLONY GAS STA FMR
BENZO[A]PYRENE (1.54 MG/KG), 
DIBENZ[A,H]ANTHRACENE (2.11 
MG/KG), GASOLINE (220 PPMV) 9/19/1997 COMMERCIAL 12K GAL, UST
Mapped 2-0011891 260 WEST MAIN ST ROADWAY RELEASE DIESEL FUEL (15 GAL) 9/19/1997 ROADWAY VEHICLE
Mapped 2-0011955 1 EAST MAIN ST CUMBERLAND FARMS FUEL OIL #2 (234 PPMV) 10/31/1997 COMMERCIAL UST
Mapped 2-0011964 50A BRIGHAM ST SAFETY KLEEN WASTE OIL (300 GAL) 11/7/1997 COMMERCIAL TANKER
Not Mapped 2-0012042 RTE 495S ROADWAY RELEASE DIESEL FUEL (100 GAL) 12/19/1997 ROADWAY VEHICLE
Mapped 2-0012190 CRANE MEADOW RD RICH PRODUCTS CORP
AMMONIA (100 LBS), AMMONIA (50 
LBS) 4/19/1998 COMMERCIAL VALVE
Not Mapped 2-0012193 AMES ST ROADWAY RELEASE
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (1 GAL) 4/22/1998 ROADWAY
1 GALLON, 
CONTAINER, PLASTIC
Mapped 2-0012207 PLEASANT ST PERRY LANE DIESEL FUEL (11 GAL) 5/3/1998
RESIDNTIAL, 
ROADWAY VEHICLE
Mapped 2-0012419 19 MAPLE ST
INTERSECTION OF 
WARREN AVE
PROPANE, 2-METHOXY-2-METHYL-
(1.4 PPM), TOTAL PETROLEUM 
HYDROCARBONS (TPH) (1200 
PPM) 6/11/1998
Mapped 2-0012274 415 MAPLE ST
VIGEANT COMMERCIAL 
PROPERTY WASTE OIL (150 PPMV) 6/30/1998
COMMERCIAL, 
INDUSTRIAL UST
Mapped 2-0012285 277 BOSTON POST RD
MAYFLOWER 
TRANSPORTATION DIESEL FUEL (50 GAL) 7/2/1998 COMMERCIAL VEHICLE
Mapped 2-0012376 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (55 GAL) 8/31/1998 COMMERCIAL DRUMS
Mapped 2-0012471 146 MAPLE ST
BAKERLY CITGO-KING 
BRAKES GASOLINE 10/23/1998 COMMERCIAL UST
Not Mapped 2-0012603 RTE 290 WESTBOUND ROADWAY RELEASE DIESEL FUEL (150 GAL) 1/15/1999 ROADWAY VEHICLE
Mapped 2-0012632 146 MAPLE ST
BAKERLY CITGO-KING 
BRAKES GASOLINE (10 GAL) 1/26/1999 COMMERCIAL
DISPENSER, 
GASOLINE
Mapped 2-0012629
85 HAYES MEMORIAL 
DR
DIAMOND MACHINING 
TECHNOLOGY INC DIESEL FUEL (20 GAL) 1/26/1999 COMMERCIAL PIPE
Mapped 2-0012695 150 CEDAR HILL ST KENS FOODS 2/5/1999
Not Mapped 2-0012696 BOSTON POST RD M & M TRANSPORT CO
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (10 GAL) 3/9/1999 ROADWAY VEHICLE
Mapped 2-0012726 301 MAPLE ST T & W REALTY TRUST
TOTAL PETROLEUM 
HYDROCARBONS (TPH) (2.5 PPM) 3/24/1999 COMMERCIAL UST
Mapped 2-0012780 146 MAPLE ST
BAKERLY CITGO-KING 
BRAKES
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 5/1/1999 GAS, PLUME
Mapped 2-0012648 301 MAPLE ST T & W REALTY TRUST
ETHANE, 1,1,2,2-TETRACHLORO- 
(.639 MG/KG), ETHENE, CHLORO- 
(2 UG/L) 5/19/1999
Mapped 2-0012797 686 STOW RD FOSSILE CONSTRUCTION DIESEL FUEL (30 GAL) 5/21/1999 ROADWAY VEHICLE
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Mapped 2-0012883 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF TYPE - 
OIL (9 GAL) 7/29/1999 COMMERCIAL DRUMS
Mapped 2-0012912
RTE 290 EASTBOUND 
AT RTE 495 ROADWAY RELEASE DIESEL FUEL (70 GAL) 8/25/1999 ROADWAY VEHICLE
Mapped 2-0012945 2 BOSTON POST RD FORMER TEXACO STA 9/14/1999
Mapped 2-0012955
33 BOSTON POST RD 
W
JOHN HANCOCK MUTUAL 
LIFE INSURANCE CO
BENZENE, METHYL- (6690 UG/L), 
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (14.3 MG/KG) 9/28/1999
Mapped 2-0012958 146 MAPLE ST CITGO STA WASTE OIL (10 GAL) 10/4/1999 COMMERCIAL UST
Mapped 2-0012964 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF TYPE - 
OIL (30 GAL) 10/4/1999 DRUMS
Mapped 2-0012985 146 MAPLE ST
BAKERLY CITGO KING 
BRAKES FUEL OIL #2 (120 PPMV) 10/6/1999 COMMERCIAL UST
Mapped 2-0012984 146 MAPLE ST KING BRAKES GASOLINE (300 PPMV) 10/15/1999 COMMERCIAL
Mapped 2-0013031
771 BOSTON POST RD 
E
MARLBOROUGH 
COMMONS MALL
ETHENE, TETRACHLORO- (560 
MG/KG) 11/16/1999 COMMERCIAL
Not Mapped 2-0013110 RTE 495 RTE 495 S AT MM 65.5 DIESEL FUEL (50 GAL) 1/2/2000 ROADWAY VEHICLE
Mapped 2-0013126 428 MAPLE ST WAYSIDE FORD
ETHENE, TETRACHLORO- (.82 
MG/KG) 1/13/2000
Mapped 2-0013153 417 MAPLE ST PREMIUM FUEL CORP FUEL OIL #2 (20 GAL) 2/9/2000 COMMERCIAL PIPE
Mapped 2-0013156 222 EAST MAIN ST COMMERCIAL PROPERTY ETHENE, CHLORO- (21 UG/L) 2/10/2000
Not Mapped 2-0013172 HILDRETH ST UTILITY POLE NO 1
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (20 GAL) 2/26/2000
MUNICIPAL, 
ROADWAY TRANSFORM
Mapped 2-0013192 271 FARM RD RESIDENCE FUEL OIL #2 (100 GAL) 3/14/2000 RESIDNTIAL AST
Mapped 2-0013193 55 FAIRBANKS BLVD LUCENT TECHNOLOGIES DIESEL FUEL (20 GAL) 3/15/2000 COMMERCIAL AST
Not Mapped 2-0013286 WEST MAIN ST
PARCEL 27 COMMERCIAL 
PROPERTY
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (63000 
UG/L) 5/3/2000
Mapped 2-0013333
193 BOSTON POST RD 
W VICTORY SUPERMARKET
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (12 GAL) 6/20/2000 COMMERCIAL PIPE
Mapped 2-0013575 656 BOSTON POST RD STARRETT FAMILY TRUST 7/10/2000
Not Mapped 2-0013392 BOSTON POST RD ROADWAY RELEASE DIESEL FUEL (20 GAL) 7/28/2000 ROADWAY VEHICLE
Not Mapped 2-0013420 PROSPECT ST UTILITY POLE NO 4-1
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (84 GAL) 8/8/2000 TRANSFORM
Not Mapped 2-0013427 BOUNDARY ST MARLBOROUGH DPW
IRON CHLORIDE (FeC13) (119 
GAL) 8/12/2000 MUNICIPAL TANKER
Not Mapped 2-0013481 STEVENS ST WATERS EDGE DEV
UNKNOWN CHEMICAL OF TYPE - 
OIL (10 GAL), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE 
(20 GAL), UNKNOWN CHEMICAL 
OF UNKNOWN TYPE (4800 PPM) 9/19/2000 COMMERCIAL VEHICLE
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Not Mapped 2-0013515 OFF CEDAR HILL RD
MWRA WALNUT HILL 
TREATMENT PLANT
BENZ[A]ANTHRACENE (1.45 PPM), 
BENZ[E]ACEPHENANTHRYLENE 
(.892 PPM), BENZO[A]PYRENE 
(1.24 PPM) 10/11/2000
Mapped 2-0013531 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 10/23/2000 COMMERCIAL DRUMS
Mapped 2-0013554 299 MAPLE ST JEMS OF NEW ENGLAND
TOTAL PETROLEUM 
HYDROCARBONS (TPH) (1500 
MG/L) 11/7/2000
Mapped 2-0013585 50 DANGELO DR BFI INC PETROLEUM BASED OIL (20 GAL) 12/1/2000 ROADWAY VEHICLE
Not Mapped 2-0013590 EWALD AVE LOT NO 31
DIESEL FUEL (10 GAL), 
PETROLEUM BASED OIL (10 GAL) 12/4/2000 RESIDNTIAL VEHICLE
Mapped 2-0013603 265 LAKESIDE AVE
HOLIDAY INN PARKING 
LOT GASOLINE (30 GAL) 12/11/2000 ROADWAY PIPE, VEHICLE
Mapped 2-0013607
MAPLE ST AND MILL 
ST RTE 85
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (20 GAL) 12/13/2000 ROADWAY TRANSFORM
Mapped 2-0013690 222 EAST MAIN ST KARNAK REALTY TRUST
ETHENE, TETRACHLORO- (.98 
UG/L) 2/14/2001 COMMERCIAL
Mapped 2-0013738 135 NEIL ST MARLBOROUGH DPW
ARSENIC (410 MG/KG), 
NAPHTHALENE (17.6 MG/KG), 
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (6.46 MG/KG) 3/16/2001
Mapped 2-0013746 65 LAKESHORE DR FORT MEADOW LAKE FUEL OIL #2 (125 GAL) 3/24/2001 RESIDNTIAL AST
Mapped 2-0013773 100 PHELPS ST TRAILER PARK LOT NO 31 FUEL OIL #2 (150 GAL) 4/8/2001
COMMERCIAL, 
RESIDNTIAL AST
Mapped 2-0013796 164 BOSTON POST RD
MCDONALDS PARKING 
LOT DIESEL FUEL (10 GAL) 4/27/2001
COMMERCIAL, 
ROADWAY VEHICLE
Not Mapped 2-0013808 RTE 495
RTE 495 S NORTH OF RTE 
290 ONRAMP DIESEL FUEL (60 GAL) 5/11/2001 ROADWAY VEHICLE
Mapped 2-0013844 81 BOSTON POST RD WASTE MGMT INC PETROLEUM BASED OIL (25 GAL) 6/11/2001 COMMERCIAL PIPE
Mapped 2-0013859 50A BRIGHAM ST SAFETY KLEEN SYSTEMS
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 6/18/2001 DRUMS
Mapped 2-0013900 114 EAST MAIN ST
FMR EXXON FACILITY NO 
35030 NAPHTHALENE (8.6 MG/KG) 7/10/2001
Mapped 2-0013950 50A BRIGHAM ST
SAFETY KLEEN SYSTEMS 
INC
2-PROPANONE, METHANE, 
TRICHLORO- 8/13/2001 DRUMS
Mapped 2-0013957 50A BRIGHAM ST SAFETY KLEEN
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (5 GAL) 8/21/2001 INDUSTRIAL DRUMS
Mapped 2-0013965
GLEN ST AND RIPLEY 
ST MILLHAM BROOK
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE 8/30/2001 WATERBODY UNKNOWN
Mapped 2-0014081 120 BARTLETT ST BUTCHER CO FUEL OIL #2 (18 INCH) 11/9/2001 INDUSTRIAL
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Mapped 2-0014120 120 BARTLETT ST THE BUTCHER COMPANY FUEL OIL #2 (237 PPMV) 12/14/2001 COMMERCIAL UST
Mapped 2-0014176 413 LAKESIDE AVE SHELL STATION
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (90.1 PPB) 2/4/2002 COMMERCIAL SRM
Mapped 2-0014194 LAKESIDE AVE
NSTAR FRONT OF 175 
LAKESIDE AVE GASOLINE 2/15/2002 RIGHTOFWAY UNKNOWN
Mapped 2-0014246 771 BOSTON POST RD
RK PINE TREE SHOPPING 
CTR
INDENO(1,2,3-CD)PYRENE (1.3 
MG/KG), UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (1.4 MG/KG), 
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (1.7 MG/KG), 
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (2.1 MG/KG) 3/26/2002
Mapped 2-0014270 529 BOSTON POST RD MOBIL FACILITY 01-794
BENZENE (35.3 UG/G), BENZENE, 
ETHYL- (140 UG/G), BENZENE, 
METHYL- (425 UG/G), 
NAPHTHALENE (32.9 UG/G), 
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (267 
UG/G), UNKNOWN CHEMICAL OF 
TYPE - OIL (555 UG/G) 4/10/2002
Not Mapped 2-0014267 WEST MAIN ST
MOBIL CORP PARCEL 27 
COMMERCIAL PROPERTY
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (452 PPB) 4/12/2002 COMMERCIAL UNKNOWN
Mapped 2-0014317 342 BOSTON POST RD SHELL STATION GASOLINE (.05 GAL/HR) 5/22/2002 COMMERCIAL DFS10349, SUMP
Mapped 2-0014341 56 JEFFERSON ST
FMR B AND M 
TURNAROUND
LEAD (.056 MG/L), LEAD (450 
MG/KG), UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (50 MG/KG), 
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (9.4 MG/KG) 6/4/2002
Mapped 2-0014385 123 FELTON ST
FELTON STREET 
ASSOCIATES ETHENE, 1,1-DICHLORO- (20 UG/L) 7/3/2002
Mapped 2-0014422 1 DANGELO DR RR TRACKS 8/6/2002
Mapped 2-0014434 260 WEST MAIN ST MOBIL STATION
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (100000 
UG/L) 8/12/2002
Mapped 2-0014439 45 BARTLETT ST ARM FACILITY
ETHENE, CHLORO- (1 LBS), 
UNKNOWN CHEMICAL OF TYPE - 
OIL (55 GAL) 8/14/2002 INDUSTRIAL DRUMS
Mapped 2-0014514 509 LINCOLN ST
LINCOLN MARLBOROUGH 
TRUST
ARSENIC (140 MG/KG), LEAD (940 
MG/KG) 10/9/2002
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Mapped 2-0014560 146 MAPLE ST KING BRAKES
BENZENE, DIMETHYL (5.8 UG/L), 
BENZENE, ETHYL- (4.1 UG/L), 
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (370 
UG/L) 11/20/2002 COMMERCIAL UST
Mapped 2-0014592
749 DONALD LYNCH 
BLVD UPPER RIVER ROAD LLC
FUEL OIL #2 (1800 MG/KG), TOTAL 
PETROLEUM HYDROCARBONS 
(TPH) (1800 PPM) 12/17/2002 COMMERCIAL UNKNOWN
Mapped C90-0798
102 HAYES MEMORIAL 
DR AIR PRODUCTS GASOLINE U.S.T.
Mapped C86-0074 146 MAPLE ST AT & T
OTHER MATERIAL, OIL 
CONTAMINATED WATER (UNK)
OTHER SOURCE, AT& 
T MANHOLE
Mapped C87-0456 175 MAPLE ST DESIGN PAK
OTHER MATERIAL, OIL (10-50 
GAL) DRUM
Mapped C89-0251 201 BROAD ST WASTE OIL
OTHER SOURCE, 
UNKNOWN
Mapped C89-0616 21 EAST MAIN ST MARLBOROUGH GARAGE GASOLINE U.S.T.
Mapped C90-0332 214 CEDARHILL RD MASS TRANSPORT INC
OTHER MATERIAL, WASTE OIL & 
MASONERY ACID DRUM
Mapped C92-0306 225 BOSTON POST RD CHARLES CHEVROLET WASTE OIL (UNK) U.S.T.
Mapped C87-0403 23 EAGER COURT WASTE OIL
OTHER SOURCE, CAR 
MOTOR OIL
Mapped C86-0210 247 MAPLE ST ABANDONED UST GASOLINE (UNK GAL) U.S.T.
Mapped C90-0513 250 LOCK DR JOHN HANCOCK INS. CO. #2 FUEL OIL (UNK GAL) U.S.T.
Mapped C90-0379 299 MAPLE ST
LANDS TOWING/MARANE 
OIL GASOLINE (UNK) U.S.T.
Mapped C85-0029
3 BELLVIEW DR, 
PORAS RESID.
#2 OIL SPILL AT 
RESIDENCE #2 FUEL OIL (251-500 GAL) ABOVE-GRND TANK
Mapped C92-0053 3 RESULTS WAY
DIGITAL EQUIPMENT 
CORP.
OTHER MATERIAL, #2 OIL 
CONTAMINATED SOIL (UNK CUBIC 
YDS) U.S.T.
Mapped C90-0663 308 LINCOLN ST CAR BATTERY DUMPING BATTERIES/BATTERY ACID (UNK)
OTHER SOURCE, 
UNKNOWN
Mapped C88-0333 424 LINCOLN ST WASTE OIL DRUM
Mapped C90-0222 431 LINCOLN ST SHELL OIL
OTHER MATERIAL, GASOLINE 
CONT. SOIL
OTHER SOURCE, 
STAGE 2 VAPOR
Mapped C93-0426 46 REYNOLDS ST
POSSIBLE RESIDENCIAL 
DUMPING
OTHER MATERIAL, 
CONSTRUCTION DEBRIS (UNK 
GAL)
OTHER SOURCE, 
DEMOLITION DEBR
Mapped C90-0140 48 WELLINGTON RUPTURED FUEL TANK #2 FUEL OIL ABOVE-GRND TANK
Not Mapped C88-0354 495 OVERPASS GASOLINE (51-100 GAL)
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Mapped C93-0210 496 LINCOLN ST MOTOR OIL DUMPING MOTOR OIL (UNK GAL)
OTHER SOURCE, 
VEHICLE
Mapped C87-0195 50 MAIN ST MOBIL STATION GASOLINE U.S.T.
Mapped C90-0348 50 MAIN ST DRAKE PETROLEUM GASOLINE U.S.T.
Mapped C93-0214 50A BRIGHAM ST SAFETY CLEAN
OTHER MATERIAL, NAPTHALENE 
(UNK GAL) DRUM
Mapped C88-0661 547 BOSTON POST RD MISCELLANEOUS OIL (10-50 GAL) ABOVE-GRND TANK
Mapped C89-0453 61 BRIGHAM RD SUPERIOR PRINTING
OTHER MATERIAL, 
INK,PAINT,VARNISH (UNK)
OTHER SOURCE, 
SPRINK. FLOOD
Mapped C90-0443 615 WILLIAM ST
RESIDENT FUEL OIL TANK 
LEAK #2 FUEL OIL ABOVE-GRND TANK
Mapped C87-0397 656 BOSTON POST RD STARRETT PAVING GASOLINE U.S.T.
Mapped C93-0180 69 SECOND RD 69 SECOND RD
OTHER MATERIAL, NOT 
SPECIFIED (< 1 GAL)
Mapped C88-0617 720 BOSTON POST RD #2 FUEL OIL U.S.T.
Not Mapped C89-0203 770 OLD POST RD RT. 20 GASOLINE (UNK) U.S.T.
Mapped C87-0466 82 FLORENCE ST MASS ELECTRIC DIESEL FUEL (UNK) U.S.T.
Mapped C92-0182 98 HOME ST TELEPHONE POLE #11
OTHER MATERIAL, CREOSOTE 
(UNK)
OTHER SOURCE, 
TELEPHONE POLE
Mapped C83-0129
BOLTON & LINCOLN 
ST SUNOCO STATION GASOLINE (UNK) U.S.T.
Not Mapped C89-0753 EAST MAIN ST EXXON STATION GASOLINE U.S.T.
Not Mapped C88-0360 ELM ST #2 FUEL OIL
Not Mapped C85-0244 FLORENCE ST, #82 MASS. ELECTRIC CO. #2 FUEL OIL (UNK GAL) U.S.T.
Not Mapped C89-0550 HAYES MEMORIAL DR
MASS ELECTRIC POLE 
#22 TRANSFORMER OIL (10-50 UNK)
OTHER SOURCE, LINE 
RECLOSER
Mapped C86-0389
M.D.C. PROP.,WALKER 
ST& RT 85 M.D.C. PROPERTY WASTE OIL (UNK)
OTHER SOURCE, 
UNKNOWN
Not Mapped C87-0323
MAIN ST IN PARKING 
LOT OFF FLORENCE ST MISCELLANEOUS OIL
OTHER SOURCE, 
UNKNOWN
Mapped C90-0315 MAPLE & HARVARD ST
N.E. TELEPHONE 
MANHOLE GASOLINE (UNK)
OTHER SOURCE, 
UNKNOWN
Not Mapped C85-0071 MARLBORO BROOK
OIL DISCHARGE TO 
BROOK MISCELLANEOUS OIL (UNK GAL)
OTHER SOURCE, 
UNKNOWN
Not Mapped C85-0125
MARLBORO 
INDUSTRIAL PARK J. HANCOCK INS CO. DIESEL FUEL (UNK) U.S.T.
Not Mapped C92-0055
MDC POND, ON MAPLE 
ST
CHRONIC SHEEN FROM 
EMBANKMENT
OTHER MATERIAL, SHEEN ON 
BROOK (SHEEN)
Mapped C89-0663 NEIL ST CITY OF MARLBOROUGH GASOLINE (UNK) U.S.T.
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
MAPPED/NOT 
MAPPED ID ADDRESS LOCATION AID MATERIALS
NOTIFICATION 
DATE LOCATION TYPE SOURCE
Not Mapped C92-0138 ON ROADSIDE
ROOF WASH AND 
BATTERIES
OTHER MATERIAL, ROOF WASH 
AND 2 BATTERIES (UNK GAL)
Not Mapped C93-0164 PLEASANT ST AREA GAS IN STORM DRAIN GASOLINE (UNK GAL)
Not Mapped C85-0189 REINGOLD ST UNKNOWN DUMPING
OTHER MATERIAL, MOTOR OIL 
AND GASOLINE (UNK GAL)
Mapped C88-0384
RT 20 AND PETERS 
AVE GASOLINE (10-50 GAL) VEH. FUEL TANK
Mapped C88-0388
RTE 20 & HAYES MEM. 
DR GASOLINE (1-10 GAL) VEH. FUEL TANK
Mapped C92-0360 RTE. 20 & CONCORD PESTICIDE SPRAYING
OTHER MATERIAL, PESTICIDE 
(UNK)
Not Mapped C91-0064 WAYSIDE INN RD
DRUM OF WASTE OIL 
LEAKING WASTE OIL (DRUM) DRUM
Not Mapped C89-0050 WILSON ST
SISTERS OF GOOD 
SHEPARD #6 FUEL OIL (UNK ) ABOVE-GRND TANK
Not Mapped C89-0317
LEAD ARSENITE 
COMTAMINATION
OTHER MATERIAL, LEAD 
ARSENITE (UNK)
OTHER SOURCE, FMR 
APPLE ORCH.
1 If a site that was identified prior to 1993 had not been closed out (i.e., its cleanup was not complete) by 1993, then it was carried forward into the new 21E database that was designed
by the Bureau of Waste Site Cleanup in 1993.
Data Source: Massachusetts Department of Environmental Protection. Bureau of Waste Site Cleanup 21E Sites Database (http://www.mass.gov/dep/cleanup/sites/sdown.htm). 
 Information contained in this table is presented as downloaded.   [Cited June 2001, July 2001, February 2002 and May 2006]
Notes:
Mapped/Not Mapped - Refers to if address information was sufficient to allow for mapping
ID - Identification number assigned to the spill/release.
Location Aid - Additional information regarding the location of the spill
Notification Date - Date MDEP was notified of the contamination
Materials - Information regarding the specific chemicals (and amounts) found at the site
Table 17 (cont.) - Environmental Release and Spill Sites in Marlborough, MA
  
 
 
 
 
 
 
 
 
 
 
 
APPENDIX A 
Risk Factor Information for Leukemia, Liver Cancer, and Lung Cancer 
 
Risk Factor Information for Leukemia 
 
 
Leukemia is the general term that includes a group of different cancers that occur in the blood 
forming organs and result in the formation of abnormal amounts and types of white blood cells in 
the blood and bone marrow.  Individuals with leukemia generally maintain abnormally high 
amounts of leukocytes or white blood cells in their blood.  This condition results in an 
individual’s inability to maintain certain body functions, particularly a person’s ability to combat 
infection. 
 
In 2006, leukemia is expected to affect approximately 35,070 individuals in the United States 
(20,000 males and 16,730 females) in the United States, resulting in 22,280 deaths. Acute cases 
of leukemia are slightly more common that chronic, 15,860 and 14,520 respectively. In 
Massachusetts, approximately 770 individuals will be diagnosed with the disease in 2006, 
representing more than 2% of all cancer diagnoses. There are four major types of leukemia: acute 
lymphoid leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL), 
and chronic myeloid leukemia (CML).  There are also a few rare types, such as hairy cell 
leukemia.  In adults, the most common types are AML (approximately 11,700 cases) and CLL 
(approximately 9,560 cases). Incidences of ALL have increased approximately 1.8% per year 
since 1988 while incidences of CLL have decreased approximately 1.9% each year since 1988. 
Leukemia is the most common type of childhood cancer, accounting for about 30% of all cancers 
diagnosed in children.  The majority (74%) of these cases are of the ALL type (ACS, 2006a). 
 
While ALL occurs predominantly among children (peaking between ages 2 and 3 years), an 
elevation in incidence is also seen among older individuals, and 1300 (one-third) of total cases of 
ALL will occur in adults. ALL risk is lowest for adults aged 25 through 50 and then begins to 
pick up (ACS, 2006b). The increase in incidence among older individuals begins at 
approximately 40-50 years of age, peaking at about age 85 (Linet and Cartwright, 1996).  ALL is 
more common among whites than African Americans and among males than females (Weinstein 
and Tarbell, 1997).  Exposure to high-dose radiation (e.g., by survivors of atomic bomb blasts or 
nuclear reactor accidents) is a known environmental risk factor associated with the development 
of ALL (ACS, 2006b).  Significant radiation exposure (e.g., diagnostic x-rays) within the first 
few months of development may carry up to a 5-fold increased risk of developing ALL (ACS, 
2006b).  However, few studies report an increased risk of leukemia associated with residing in 
proximity to nuclear plants or occupational exposure to low-dose radiation (Linet and Cartwright, 
1996; Scheinberg et al., 1997).  There is conflicting evidence about whether exposure to 
electromagnetic fields (EMF) plays a role in the development of ALL, however, most studies to 
date have found little or no risk (ACS, 2006b). 
 
Few other risk factors for ALL have been identified.  There is evidence that genetics may play an 
important role in the development of this leukemia type.  Studies indicate that siblings of twins 
who develop leukemia are at an increased risk of developing the disease.  Children with Down’s 
syndrome are 10 to 20 times more likely to develop acute leukemia (Weinstein and Tarbell, 
1997).  In addition, other genetic diseases, such as Li-Fraumeni syndrome and Klinefelter’s 
syndrome, are associated with an increased risk of developing leukemia.  Patients receiving 
medication that suppresses the immune system (e.g., organ transplant patients) may be more 
likely to develop ALL (ACS, 2006c).  ALL has not been definitively linked to chemical exposure, 
however, childhood ALL may be associated with maternal occupational exposure to pesticides 
during pregnancy (Infante-Rivard et al., 1999).  Certain rare types of adult ALL are caused by 
human T-cell leukemia/lymphoma virus-I (HTLV-I) (ACS, 2006c).  Some reports have linked 
other viruses with various types of leukemia, including Epstein-Barr virus and hepatitis B virus.  
Still others propose that leukemia may develop as a response to viral infection.  However, no 
specific virus has been identified as related to ALL (Linet and Cartwright, 1996).  Reports also 
suggest an infectious etiology for some childhood ALL cases, although a specific viral agent has 
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not been identified and findings from studies exploring contact among children in day-care do not 
support this hypothesis (Greaves MF, 1997; Kinlen and Balkwill, 2001; Rosenbaum et al., 2000). 
 
Although AML can occur in children (usually during the first two years of life), AML is the most 
common leukemia among adults, with an average age at diagnosis of 65 years (ACS, 2006d).  
This type of leukemia is more common among males than among females but affects African 
Americans and whites at similar rates (Scheinberg et al., 1997).  High-dose radiation exposure 
(e.g., by survivors of atomic bomb blasts or nuclear reactor accidents), long-term occupational 
exposure to benzene (a chemical in gasoline and cigarette smoke), and exposure to certain 
chemotherapy drugs, especially alkylating agents (e.g., mechlorethamine, cyclophosphamide), 
have been associated with an increased risk of developing AML among both children and adults 
(ACS, 2006d).  The development of childhood AML is suspected to be related to parental 
exposure to pesticides and other chemicals, although findings are inconsistent (Linet and 
Cartwright, 1996).  Studies have suggested a link between electromagnetic field (EMF) exposure 
(e.g., from power lines) and leukemia (Minder and Pfluger, 2001; Schuz et al., 2001).  However, 
there is conflicting evidence regarding EMF exposure and leukemia and it is clear that most cases 
are not related to EMF (Kleinerman et al., 2000). 
  
Other possible risk factors related to the development of AML include cigarette smoking and 
genetic disorders.  It is estimated that approximately one-fifth of cases of AML are caused by 
smoking (Scheinberg et al., 1997).  Also, a small number of AML cases can be attributed to rare 
inherited disorders, such as Down’s syndrome (ACS, 2006d).  Recently, scientists have suggested 
that a mutation in a gene responsible for the deactivation of certain toxic metabolites may have 
the ability to increase the risk of acute myeloid leukemia in adults.  However, further research is 
necessary in order to confirm the findings of this study (Smith et al., 2001).  
 
CLL is chiefly an adult disease; the average age at diagnosis is about 70 years (ACS, 2006e). 
Twice as many men as women are affected by this type of leukemia (Deisseroth et al., 1997).  
While genetics and diseases of the immune system have been suggested as playing a role in the 
development of CLL, high-dose radiation and benzene exposure have not (ACS, 1999; Weinstein 
and Tarbell, 1997).  It is thought that individuals with a family history of CLL are two to four 
times as likely to develop the disease.  Some studies have identified an increased risk of 
developing CLL (as well as ALL, AML, and CML) among farmers due to long-term exposure to 
herbicides and/or pesticides (Linet and Cartwright, 1996).  Although viruses have been implicated 
in the etiology of other leukemias, there is no evidence that viruses cause CLL (Deisseroth et al., 
1997). 
 
Of all the leukemias, CML is among the least understood.  While this disease can occur at any 
age, CML is extremely rare in children (about 2% of leukemias in children) and the average age 
of diagnosis is 40 to 50 years (ACS, 2006f).  Incidence rates are higher in males than in females, 
but unlike the other leukemia types, rates are higher in blacks than in whites in the U.S. (Linet 
and Cartwright, 1996).  High-dose radiation exposure may increase the risk of developing CML 
(ACS, 2006f).  Finally, CML has been associated with chromosome abnormalities such as the 
Philadelphia chromosome (Weinstein and Tarbell, 1997). 
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An estimated 18,510 people in the U.S. (12,600 men and 5,910 women) will be diagnosed with 
liver and intrahepatic bile duct cancer in 2006, accounting for approximately 1% of all new 
cancers (ACS 2006).  Hepatocellular carcinoma (HCC) is the most common primary cancer of 
the liver and accounts for about 75% of all cases.  Rarer forms of malignant liver cancer include 
the fibrolamellar subtype of HCC, cholangiocarcinoma, and angiosarcomain adults and 
hepatoblastoma in children.  Cholangriocarcinomas account for approximately 10% to 20% of all 
primary liver cancers and people with gallstones, gall bladder inflammation, chronic ulcerative 
colitis (long-standing inflammation of the large bowel) or chronic infection with certain types of 
parasitic worms are at an increased risk for developing this cancer.  Hepatoblastoma is a rare 
cancer that forms usually in children under age 4 and has a 90% survival rate with early detection 
(ACS 2006a). 
 
In some developing countries, HCC is most common type of cancer diagnosed particularly in 
East Asia and Africa.  Incidence in the United States had been increasing up to 1999.  Recently, 
the rate has become more stable (ACS 2006a).  Rates of HCC in the U.S. had increased by 70% 
during the 1980s and 1990s (Yu et al. 2000).  Similar trends were observed in Canada and 
Western Europe.  The primary reason for the higher rates observed during those years was the 
increase in hepatitis C virus infection, an important factor related to liver cancer (El-Serag 2001; 
El-Serag and Mason 2000).   
 
Men are at least three times more likely to develop HCC than women.  Much of this is likely due 
to differences in lifestyle factors which increase a person’s risk for developing liver cancer (ACS 
2006a).  Although 85% of individuals diagnosed with liver cancer are between 45 and 85 years of 
age, the disease can occur in persons of any age (ACS 2006a). 
 
Several important risk factors for liver cancer have been identified.  Chronic infection with 
hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most significant risk factors for 
developing liver cancer (ACS 2006a).  It is estimated that 80% of HCC cases worldwide can be 
attributed to HBV infection (Yu et al. 2000).  In the United States, HBV accounts for less than a 
quarter of the cases and infection with HCV plays a much larger role in the incidence of this 
cancer.  HBV and HCV can be spread through intravenous drug use (e.g., the sharing of 
contaminated needles), unprotected sexual intercourse, and transfusion of and contact with 
unscreened blood and blood products.  In addition, mothers who are infected with these viruses 
can pass them on to their children at birth or in early infancy (ACS 2006a). 
 
Cirrhosis is also a major risk factor for the development of liver cancer.  Cirrhosis is a progressive 
disease that is the result of scar tissue formation on the liver, which can lead to cancer.  
Researchers estimate that 60% to 80% of HCC cases are associated with cirrhosis.  However, it is 
unclear if cirrhosis itself causes liver cancer or if the underlying causes of cirrhosis contribute to 
the development of this disease (Garr et al. 1997).  Most liver cirrhosis in the U.S. occurs as a 
result of chronic alcohol abuse, but HBV and HCV are also major causes of cirrhosis (ACS 
2006a).  In addition, certain inherited metabolic diseases, such as hemochromatosis, which causes 
excess iron accumulation in the body, can lead to cirrhosis (ACS 2006a).  Some studies have 
shown that people with hemochromatosis are at an increased risk of developing liver cancer 
(Fracanzani et al. 2001). 
 
Epidemiological and environmental evidence indicates that exposure to certain chemicals and 
toxins can also contribute significantly to the development of liver cancer.  For example, chronic 
consumption of alcoholic beverages has been associated with liver cancer (Wogan 2000).  As 
noted above, it is unclear if alcohol itself causes HCC or if underlying cirrhosis is the cause 
(London and McGlynn 1996).  However, it is clear that alcohol abuse can accelerate liver disease 
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and may act as a co-carcinogen in the development of liver cancer (Ince and Wands 1999).  Long-
term exposure to aflatoxin can also cause liver cancer.  Aflatoxins are carcinogenic agents 
produced by a fungus found in tropical and subtropical regions.  Individuals may be exposed to 
aflatoxins if they consume contaminated peanuts and other foods that have been stored under hot, 
humid conditions (Wogan 2000).  Vinyl chloride, a known human carcinogen used in the 
manufacturing of some plastics, and thorium dioxide, used in the past for certain x-ray tests, are 
risk factors for a rare type of liver cancer called angiosarcoma (ACS 2006a; London and 
McGlynn 1996).  These chemicals may also increase the risk of cholangiocarcinoma and HCC, 
but to a lesser degree.  The impact of both thorium dioxide and vinyl chloride on the incidence of 
liver cancer was much greater in the past, since thorium dioxide has not been used for decades 
and exposure of workers to vinyl chloride is now strictly regulated in the U.S. (ACS 2006a).  
Drinking water contaminated with arsenic may increase the risk of liver cancer in some parts of 
the world (ACS 2006a; ATSDR 2001). 
 
The use of oral contraceptives by women may also be a risk factor in the development of liver 
cancer.  However, most of the studies linking oral contraceptives and HCC involved types of oral 
contraceptives that are no longer used.  There is some indication that the increased risk may be 
confined to oral contraceptives containing mestranol.  It is not known if the newer oral 
contraceptives, which contain different types and doses of estrogen and different combinations of 
estrogen with other hormones, significantly increase the risk of HCC (ACS 2006a; London and 
McGlynn 1996).  Long-term anabolic steroid use may slightly increase the risk of HCC (ACS 
2006a).  Although many researchers believe that cigarette smoking plays a role in the 
development of liver cancer, the evidence for this is still inconclusive (Mizoue et al. 2000; 
London and McGlynn 1996). 
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Lung cancer generally arises in the epithelial tissue of the lung.  Several different 
histologic or cell types of lung cancer have been observed.  The various types of lung 
cancer occur in different regions of the lung and each type is associated with slightly 
different risk factors (Blot and Fraumeni 1996).  The most common type of lung cancer 
in the United States today is adenocarcinoma which accounts for about 40% of all lung 
cancers (ACS 2005).  The greatest established risk factor for all types of lung cancer is 
cigarette smoking, followed by occupational and environmental exposures. 
 
The incidence of lung cancer increases sharply with age peaking at about age 60 or 70.  
Lung cancer is very rare in people under the age of 40.  The incidence is greater among 
men than women (probably because men are more likely to be smokers than women) and 
among blacks than whites (Blot and Fraumeni 1996).  The American Cancer Society 
estimates that lung and bronchus cancer will be diagnosed in 174,470 people (92,700 
cases in men and 81,770 in women) in the U.S. in 2006, accounting for about 12% of all 
new cancer diagnoses. For purposes of treatment, lung cancer is divided into two clinical 
groups: small cell lung cancer (13%) and non-small cell lung cancer (87%) (ACS 2006).  
Lung cancer is the leading cause of cancer death among both men and women; more 
people die of lung cancer than of colon, breast, and prostate cancers combined (ACS 
2005).  In Massachusetts, an estimated 4,070 individuals will be diagnosed with lung and 
bronchus cancer in 2006.  Incidence rates for lung and bronchus cancer in Massachusetts 
from 1998 through 2002 were 86.5 per 100,000 and 60.4 per 100,000 for males and 
females, respectively (ACS 2006).  Nationwide, the incidence rate declined significantly 
in men during the 1990s, most likely as a result of decreased smoking rates over the past 
30 years.  Rates for women are approaching a plateau, after a long period of increase. 
This is likely because decreasing smoking patterns among women have lagged behind 
those of men (ACS 2006).  Trends in lung cancer incidence suggest that the disease has 
become increasingly associated with populations of lower socioeconomic status, since 
these individuals have higher rates of smoking than individuals of other groups (Blot and 
Fraumeni 1996). 
 
Approximately 87% of all lung cancers are caused directly by smoking cigarettes and 
some of the rest are due to exposure to second hand smoke, or environmental tobacco 
smoke.  The longer a person has been smoking and the higher the number of cigarettes 
smoked per day, the greater the risk of lung cancer.  Smoking cessation decreases the 
elevated risk and ten years after smoking cessation the risk is reduced by one-third of 
what it would have been had smoking continued. However, former smokers still carry a 
greater risk than those who have never smoked.  There is no evidence that smoking low 
tar or “light” cigarettes reduces the risk of lung cancer and mentholated cigarettes are 
thought to increase the risk of lung cancer.  Additionally, breathing secondhand smoke 
also increases an individual’s risk of developing lung cancer. A nonsmoking spouse of a 
smoker has a 30% greater risk of developing lung cancer than the spouse of a nonsmoker 
(ACS 2005). 
 
Workplace exposures have also been identified as playing important roles in the 
development of lung cancer.  Occupational exposure to asbestos is an established risk 
factor for this disease; asbestos workers are about seven times more likely to die from 
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lung cancer than the general population (ACS 2005).  Underground miners exposed to 
radon and uranium are at an increased risk for developing lung cancer (Samet and Eradze 
2000).  Chemical workers, talc miners and millers, paper and pulp workers, carpenters, 
metal workers, butchers and meat packers, vineyard workers, carpenters and painters, and 
shipyard and railroad manufacture workers are some of the occupations associated with 
an increased risk of lung cancer (Blot and Fraumeni 1996; Pohlabeln et al. 2000).  In 
addition to asbestos and radon, chemical compounds such as arsenic, chloromethyl 
ethers, chromium, vinyl chloride, nickel chromates, coal products, mustard gas, ionizing 
radiation, and fuels such as gasoline are also occupational risk factors for lung cancer 
(ACS 2005; Blot and Fraumeni 1996).  Industrial sand workers exposed to crystalline 
silica are also at an increased risk for lung cancer (Rice et al. 2001; Steenland and 
Sanderson 2001).  Occupational exposure to the compounds noted above in conjunction 
with cigarette smoking dramatically increases the risk of developing lung cancer (Blot 
and Fraumeni 1996). 
 
As noted above, exposure to radon (a naturally occurring radioactive gas produced by the 
breakdown of radium and uranium) has been associated with increased risk of developing 
lung cancer among miners.  Recently, a number of studies have demonstrated that 
exposure to elevated levels of residential radon may also increase lung cancer risk (Lubin 
and Boice 1997; Kreienbrock et al. 2001; Tomasek et al. 2001).  Epidemiological 
evidence suggests that radon may be the second leading cause of lung cancer after 
smoking (Samet and Eradze 2000).  However, actual lung cancer risk is determined by 
cumulative lifetime exposure to indoor radon.  Therefore, normal patterns of residential 
mobility suggest that most people living in high-radon homes experience lifetime 
exposures equivalent to residing in homes with lower radon levels (Warner et al. 1996). 
 
Some types of pneumonia may increase the risk of lung cancer due to scarred lung tissue 
(ACS 2002).  In addition, people who have had lung cancer have a higher risk of 
developing another tumor.  A family history of lung cancer also increases an individual’s 
risk this is due to an abnormality on chromosome 6 (ACS 2005). 
 
Air pollution may increase the risk of developing lung cancer in some cities.  However, 
this risk is much lower than that due to cigarette smoking (ACS 2005). 
 
Diet has also been implicated in the etiology of lung cancer, however, the exact 
relationship is unclear.  Diets high in fruits and vegetables decrease lung cancer risk, but 
the reasons for this are unknown (Brownson et al. 1998).  A study showed a positive 
association between total fat, monounsaturated fat, and saturated fat and lung cancer 
among males, however, this effect was not observed among women (Bandera et al. 
1997). 
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